日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  19(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture Progress in Chemotherapy for Advanced Cancer--From Leukemia to Solid Tumor / K.Kimura / p163~163
  • Special Lecture 1.Cancer Immunology:Monoclonal Antibodies, Vaccines and Tumor Necrosis Factor / L.J.Old / p164~165
  • Special Lecture 2.Strategies for the Chemotherapy of Solid Tumors / J.R.Bertino / p166~166
  • Special Lecture 3.Recent Advance in the Diagnosis of Esophageal and Colo-rectal Cancer / H.Shirakabe / p167~167
  • Symposium 1 New Tumor Marker / / p168~176
  • 1.Structural Change of the Sugar Chains of Glycoproteins by Cell Transformation and Its Application to the Diagnosis of Cancer / A.Kobata / p168~168
  • 2.Serological Typing with Monoclonal Antibodies for Classification of Hematopoietic Tumors / R.Ueda et al. / p169~169
  • 3.Human Gastrointestinal Tumor Markers Defined by Monoclonal Antibodies / K.Imai et al. / p170~170
  • 4.A Monoclonal Antibody Reactive with Gastric Carcinoma / T.Sekine / p171~171
  • 5.Immunodiagnosis of Gastric, Colorectal and Pancreatic Carcinoma with a Monoclonal Antibody against the Gastrointestinal Tumor-associated Antigen CA 19-9 / M.Herlyn / p172~172
  • 6.Pancreatic Oncofetal Antigen(POA) and Carcinoma of the Pancreas / T.Homma / p173~173
  • 7.Novel γ-Glutamyl Transpeptidase Isoenzyme and Hepatocellular Carcinoma / N.Sawabu et al. / p174~174
  • 8.Evaluation of Neuron-specific Enolase as a New Tumor Marker for Carcinoma of the Lung / Y.Ariyoshi / p175~175
  • 9.Tumor-antigen TA-4 of Squamous Cell Carcinoma in Patients with Cervical Cancer / H.Kato / p176~176
  • Symposium 2 Enhancement of Effects of Cancer Chemotherapy--New Trials and Results / / p177~183
  • 1.Chemical Modification of Anticancer Agents in the Viewpoints of Their Pharmacokinetics / H.Fujita / p177~177
  • 2.Clinical Studies on Induced Hypertension Chemotherapy Based on the Functional Characteristics of Microcirculation of Tumor Vessels / A.Wakui et al. / p178~178
  • 3.Reversal of Acquired Resistance to Vinca Alkaloids and Anthracycline Antibiotics by Calcium Channel Blockers and Calmodulin Inhibitors / T.Tsuruo / p179~179
  • 4.Regulation of Enzyme Activities Involved in Pyrimidine Synthesis and Its Application Cancer Chemotherapy / T.Shirasaka et al. / p180~180
  • 4'.UFT and UFTM Treatment for Gastric Cancer / S.Suga / p181~181
  • 5.Synergistic Antitumor Effect of Poly(ADP-Ribose) Synthesis Inhibitor and DNA-Damaging Agent / M.Fukushima et al. / p182~182
  • 6.Effect of Intra-aortic PGE Infusion in Patients with Neuroblastoma--Differentiation Induction and Potentiation of Chemotherapy / S.Imashuku / p183~183
  • Symposium 3 Problems and Course for the Future in Mass Screening for Cancer / / p184~188
  • 1.Present Problems and Future Progress of Gastric Mass Survey in Japan / S.Hisamichi / p184~184
  • 2.Not Received / /
  • 3.Future Countermeasures for Early Detection of Lung Cancer / T.Naruke / p185~185
  • 4.The Problems and the Course for the Future in the Mass Screening for the Cancer--Glandula Mammaria / H.Watanabe / p186~186
  • 5.Problems in Mass Screening Program for Prostatic Diseases / H.Watanabe / p187~187
  • 6.Mass Screening for Colorectal Cancer / S.Kobayashi / p188~188
  • Symposium 4 Problems in Treatment of Early Cancer / / p189~198
  • 1.Problems in Treating Early Cases of Head and Neck Cancer / M.Hirano / p189~189
  • 2.Controversy on Treatment of Early Breast Cancer / K.Enomoto et al. / p190~190
  • 2'.Some Problems in the Treatment of Early Breast Cancer / M.Izuo / p191~191
  • 3.Present and Future Problems in the Treatment of Early Lung Cancers / K.Suemasu et al. / p192~192
  • 4.Controversy for Treatment of Early Esophageal Cancer / M.Endo / p193~193
  • 5.The Problem and the Present Status of Surgical Treatment for Early Gastric Cancer / M.Nishi et al. / p194~194
  • 6.Problems on Treatment of Early Cancer--Pancreatic Cancer / K.Takagi / p195~195
  • 7.Treatment of Early Cancer--Large Bowel Cancer / K.Kato / p196~196
  • 8.Problems in the Treatment of Early Stage Urogenital Cancer / K.Koiso et al. / p197~197
  • 9.Problem on Treatment for Early Carcinoma of the Uterine Cervix / T.Yamabe / p198~198
  • Symposium 5 Function Preservation in Cancer Therapy / / p199~204
  • 1.Treatment of Maxillary Cancer--Strategy to Avoid Post-operative Cosmetic and Functional Disabilities / M.Morita / p199~199
  • 2.Breast Cancer / K.Kuno / p200~200
  • 3.Radical Operation for Rectal Cancer to Preserve Anorectal,Urinary and Sexual Function / S.Kodaira et al. / p201~201
  • 4.The Problems on the Preservation Treatment of the Vesical Function for the Bladder / K.Matsumoto / p202~202
  • 5.Functional Saving in the Treatment of Cervical Cancer / K.Sekiba / p203~203
  • 6.Malignant Bone Tumors / I.Maeyama / p204~204
  • Symposium 6 Multidisciplinary Treatment for Undifferentiated Carcinoma--Scirrhous Carcinoma in the Stomach and Small Cell Carcinoma in the Lung / / p205~214
  • 1.Scirrhous Cancer of the Stomach Its Pathology and Histogenesis / I.Kino / p205~205
  • 2.Biological Characteristics of Small-Cell Carcinoma of the Lung / T.Kameya / p2O6~2O6
  • 3.The Chemotherapy of Unresectable Borrmann Type 4 Gastric Cancer / M.Kurihara et al. / p207~207
  • 4.Surgical Treatment of Borrmann 4-type(Diffuse) Gastric Cancer / M.Hirono / p208~208
  • 4'.Treatment Methods Based on Extensions of Macroscopical Subtypes in Type Borrmann-4 of Gastric Carcinoma / T.Iwanaga / p209~209
  • 5.Small Cell Carcinoma of the Lung--From the Surgical Point of View / K.Oho / p210~210
  • 6.Combination Chemotherapy with a Multimodality Approach for Small Cell Lung Cancer / T.Ohnoshi / p211~211
  • 6.'Correlation between the Therapeutic Response and the Type of Development of Small Cell Lung Cancer / Akira Suzuki / p212~212
  • 4''.The Result of Chemo-endocrine Therapy for Female Patients with Diffuse Carcinoma of the Stomach / H.Kitaoka / p213~213
  • 4'''.Proliferation of Scirrhous Type of Gastric Carcinoma and Its Treatment / H.Kamei / p214~214
  • Symposium 7 Characteristics and Treatment of Metastases to Central Nervous System / / p215~222
  • 1.Characteristics and Treatment of CNS Metastases in Lung Cancer / H.Ikegami / p215~215
  • 2.Characteristics and Treatments of the Patients with Central Nervous System Metastases of Breast Cancer / T.Tominaga / p216~216
  • 3.Acute Leukemia / T.Fujimoto / p217~217
  • 4.Cerebral Metastasis of Choriocarcinoma / S.Kaseki et al. / p218~218
  • 5.Surgical Treatment of Brain Metastases / J.Yamashita / p219~219
  • 6.Radiation Therapy of Brain Metastases / K.Hata / p220~220
  • 7.Multidisciplinary Treatment of Metastatic Brain Tumor and Its Fundamental Studies for Chemo-immunotherapy / T.Kobayashi / p221~221
  • 8.Nuclear Magnetic Resonance Imaging of Metastatic Brain Tumors / T.Araki / p222~222
  • Symposium 8 Cancer Surgery--Concerning Extension of Operation / / p223~234
  • 1.The Advantage and Limit of Surgical Therapy to Esophageal Cancer / S.Abo et al. / p223~223
  • 2.Extent of Lymphnode Dissection and Prognosis / K.Isono / p224~224
  • 3.Surgical Treatment of Carcinoma of the Stomach Invading to Gastro-Esophageal Junction / K.Sasaki et al. / p225~225
  • 4.Carcinoma of the Upper Portion of the Stomach:Total Gastrectomy or Proximal Partial Gastrectomy? / N.Kaibara et al. / p226~226
  • 5.Critical Evaluation of Prophylactic Splenectomy in Total Gastrectomy for the Stomach Cancer / K.Sugimachi et al. / p227~227
  • 6.Radical Surgery for Advanced Bowel Cancer with Involvement to Adjacent Viscera or Distant Metastasis--Coincidental Resection of the Involved Organ / K.Hojo / p228~228
  • 7.Large Intestinal Cancer Surgery,Effective Excisional Area on the Stand-point of Lymphnode Dissection / T.Takahashi / p229~229
  • 8.Boundaries for Resection and Lymph Node Dissection in Terms of Preservation of Postoperative Functions and Radicality of the Cancer of the Colon and Rectum / M.Yasutomi / p230~230
  • 9.Indication of Extended Hepatectomy for Liver Cancer / T.Noguchi / p231~231
  • 10.Indication of Minimized Regional Operation for Primary Liver Cancer / Y.Nakanishi et al. / p232~232
  • 11.Extended Type of Pancreatectomy and Physiological Reconstruction for Cancer of the Pancreas / T.Suzuki et al. / p233~233
  • 12.Carcinoma of the Pancreas-Mode of Spread and Magnitude of Surgical Management / H.Yamauchi et al. / p234~234
  • Symposium 9 Evaluation of Sensitivity for Anti-cancer Agents Correlated with Clinical Effectiveness / / p235~245
  • 1.Clinical Evaluation on the Sensitivity Test for Anti-cancer Agents in Malignant Bone and Soft-tissue Tumors / S.Takeuchi et al. / p235~235
  • 2.In vitro Chemosensitivity Test of Human Solid Cancers
  • ³H-thymidine Uptake Inhibition Test / Y.Hanatani et al. / p236~236
  • 3.Application of Radioactive Precursors for the Evaluation of Sensitivity of Cancer Cells to Anticancer Drugs / H.Ichihashi et al. / p237~237
  • 4.Anticancer Drug Sensitivity Tested by the Tumor Stem Cell Assay / S.Hiraki / p238~238
  • 5.Chemosensitivity Testing for Human Ovarian Cancer on in vitro Colony Assay / K.Inoue / p239~239
  • 6.Predictive Drug Testing by Clonogenic Assay--Tumor Heterogeneity as Regards Drug Sensitivities / N.Tanigawa et al. / p240~240
  • 7.Establishment of Human Tumor Cell Lines in Nude Mice in Ascitic Form and Application to the Screening System of Antitumor Agents / T.Kitahara / p241~241
  • 8.Experimental Chemotherapy of Human Gastrointestinal and Breast Cancer Xenografts in Nude Mice with Drugs in Clinical Use and under Development,with Special Reference to Their Predictability to Clinical Effects / M.Fujita et al. / p242~242
  • 9.Anti-cancer Drug Sensitivity Test against Xeno-grafts of Malignant Human Lung Tumor / M.Kitano / p243~243
  • 10.Sensitivity Test of Anticancer Agents Using Human Tumor Xenografts in Nude Mice with Special Reference on Correlation between Clinical Effects and Chemotherapy / Y.Nosoh et al. / p244~244
  • 11.Histological Evaluation of Cancer Chemotherapy on Rat Ovarian Cancer--A Comparison with Human Case / T.Nishida / p245~245
  • Symposium 10 Countermeasure to Side Effects of Cancer Chemotherapy and Radiotherapy / / p246~251
  • 1.Myelotoxicity due to Cancer Chemotherapy--Autologous Bone Marrow Transplantation for the Treatment of Malignant Tumors / S.Nakamura / p246~246
  • 2.Gastrointestinal Disturbance by Cancer Chemotherapy--Recent Progress in Antiemetic Regimens / M.Murakami / p247~247
  • 3.Chronic Cardiotoxicity of Anthracycline Derivatives and Possible Prevention by CoenzymeQ¹⁰ / M.Tashima et al. / p248~248
  • 4.Interstitial Pneumonitis-fibrosis Induced by the Administration of Cytotoxic Agents / K.Oizumi / p249~249
  • 5.Pulmonary Side Effects of Radiation Therapy / Y.Imajo / p250~250
  • 6.Radiation Induced Late Effect of Central Nervous System / M.Kakehi / p251~251
  • Panel Discussion 1 Efficacy and Problems of Cancer Immunotherapy / / p252~255
  • 1.A Controlled Study of Surgical Adjuvant Chemoimmunotherapy for Advanced Gastric Cancer--The Third Study of Tokai Cooperative Study Group for Adjuvant Chemoimmunotherapy of Stomach Cancer / M.Yasue et al. / p252~252
  • 2.Adjuvant Immunotherapy of Gastric Cancer / R.Hayashi et al. / p252~252
  • 3.Prognostic Factor Analysis of Postoperative Adjuvant Immunotherapy in Gastric Carcinoma / Y.Miyamoto et al. / p252~252
  • 4.Evaluation and Improvement of Immunotherapy in Cancer Patients / T.Toge et al. / p253~253
  • 5.Factors Enhancing the Efficacy of Immunotherapy for Gastric Cancer / H.Miwa et al. / p253~253
  • 6.Sequential Combination Chemoimmunotherapy for Advanced Carcinoma / S.Arinaga et al. / p253~253
  • 7.Effect of Intrapleural Instillation of N-CWS against Lung Cancer as an Adjuvant Immunotherapy / K.Yasumoto et al. / p254~254
  • 8.Effects of Specific Active Immunotherapy on Acute Lymphoblastic Leukemia in Children / H.Yamamoto et al. / p254~254
  • 9.Immunological Function and the Effect of Immunotherapy in Protein--Deficient Mice / M.Akimoto et al. / p254~254
  • 10.Analysis of Immunosuppressive Mechanism in Anti-cancer Immunity and Immunoaugmentation by Newly Established Biological Response Modifiers / Y.Kohgo et al. / p255~255
  • Panel Discussion 2 Double Cancer and Second Cancer Following Cancer Therapy / / p256~258
  • 1.Neoplasma Following Therapeutic Irradiation for Malignant Conditions in Head and Neck Lesion / K.Ichikawa et al. / p256~256
  • 2.The Double Cancer in Alimentary Tract / T.Mori et al. / p256~256
  • 3.Clinical Significance of Second Primary Cancers in the Large Intestine and Stomach / I.Fukuda et al. / p256~256
  • 4.Multiple Primary Neoplasms: One of Which was Lung Cancer / R.Tsuchiya et al. / p257~257
  • 5.Primary Malignant Tumors among Breast Cancer Patients / F.Kasumi et al. / p257~257
  • 6.Double Primary Malignancies after the Treatment of Breast Cancer / S.Miura et al. / p257~257
  • 7.Second Primary Malignant Tumors Following Therapy for Carcinoma of the Uterine Cervix / T.Hamada et al. / p258~258
  • 8.Double Cancer Observed from Occupational and Environmental Bladder Cancer / M.Matsushima et al. / p258~258
  • Panel Discussion 3 Long-term Survivals in Cancer Chemotherapy / / p259~263
  • 1.Studies on Long-Term Survivors with Advanced Gastrointestinal Cancer / H.Takahashi et al. / p259~259
  • 2.Long-term Survival of the Patients with Gastrointestinal Cancer Received Anti-cancer Chemotherapy / Y.Sasaki et al. / p259~259
  • 3.Long Time Survivals in Cancer Chemotherapy / I.Nakao et al. / p259~259
  • 4.Long Term Survivals after Absolutely Non-curative Resection of the Stomach Cancer / O.Takeuchi et al. / p260~260
  • 5.Long Survival Patients with Hepatocellular Carcinoma Treated with Arterial Infusion of Anticancer Agents / T.Tsuburaya et al. / p260~260
  • 6.Long Survivors of Non Small Cell Lung Cancer Patients with Cancer Chemotherapy / M.Yamamoto et al. / p260~260
  • 7.Clinical Study of Prognostic Factors of Metastatic Breast Cancer Patients / M.Kitamura et al. / p261~261
  • 8.The Study on the Long Term Survived Patients with Brain Tumors Treated with ACNU and PSK after Surgery / Y.Saito et al. / p261~261
  • 9.Two Cases of Uterine Cervical Cancer Living Well over 10 Years after Chemotherapy for the Recurrence / T.Kasamatsu et al. / p261~261
  • 10.Clinical Evaluation of Chemoimmunotherapy for Uterine Cervical Cancer / H.Taniguchi et al. / p262~262
  • 11.Long Term Examination of the Patients with Oral Squamous Cell Carcinoma Which Disappeared Clinically by Bleomycin Therapy / T.Amagasa et al. / p262~262
  • 12.Long-term Follow-up of Patients with Malignant Lymphoma Treated with Combination Chemotherapy / R.Nishihara et al. / p262~262
  • 13.Long-term Survivors of Acute Leukemia in Japan / K.Kawashima et al. / p263~263
  • Panel Discussion 4 Hyperthermia / / p264~266
  • 1.A Study the Combined Effect of Radiation and Hyperthermia / Y.Kawada et al. / p264~264
  • 2.The Development of Electromagnetic Wave Applicators for Intraluminal Hyperthermia:Experimental and Clinical Results / H.Kai et al. / p264~264
  • 3.Hyperthermic Therapy on Urogenital Malignancies: Application of Shortwave Radiofrequency(RF) / Y.Kubota et al. / p264~264
  • 4.Regional Hyperthermia in the Treatment of Locally Advanced Deepseated Malignancy / S.Yanagawa et al. / p265~265
  • 5.Clinical Significance of Hyperthermia Combined with Radiotherapy / T.Matsuda et al. / p265~265
  • 6.Clinical Results of Radiothermotherapy in the Treatment of Refractory Cancers / M.Hiraoka et al. / p265~265
  • 7.Hyperthermochemotherapy for Unresectable Pancreatic Cancer / Y.Yamamoto et al. / p266~266
  • 8.Continuous Hyperthermic Peritoneal Perfusion with Large Dose of Mitomycin C in the Treatment and the Prophylaxis of Peritoneal Metastasis in Gastric Cancer Surgery / R.Hamazoe et al. / p266~266
  • 9.Clinical Result of S-HT in Combination with Chemotherapy and Radiotherapy / M.Hosoi et al. / p266~266
  • Panel Discussion 5 New Approach in Cytological Diagnosis / / p267~270
  • 1.The Application of Immunoperoxidase Technique to Cytology-Detection of CEA by Immunoelectron Microscopic Studies / H.Hata et al. / p267~267
  • 2.Immunohistological Approach to the Clinical Cytology by Detection of Cancer Markers Using Immunoperoxidase Technique / K.Nishida et al. / p267~267
  • 3.study of Cancer Cell Kinetics by means of Quantitative Cytochemistry / C.Konaka et al. / p267~267
  • 4.Application of Flow Cytometry to the Gynecological Cytology / T.Kagabu et al. / p268~268
  • 5.Application of Fine Nozzle Jet Method for the Preparation of Specimens Suitable to High Resolution Cell Image Analysis / M.Danno et al. / p268~268
  • 6.Percutaneous Transabdominal Fine Needle Aspiration Cytology of Regional Lymph Nodes of Genitourinary Cancer / S.Hoshi et al. / p268~268
  • 7.Diagnostic Significance of Bile Cytology in Obstructive Jaundice / Y.Iitsuka et al. / p269~269
  • 8.Cytology of Bladder Carcinoma by Chromosome Analysis / T.Nagayama / p269~269
  • 9.Cytological Diagnosis of Carcinoma of the Prostate: An Use of Specially Designed Prostatic Fluid Obtaining Catheter / S.Ichijo et al. / p269~269
  • 10.Scanning Electron Microscopy on Human Urinary Cytology / H.Kumon et al. / p270~270
  • 11.Mass Screening for Urinary Tract Cancer with Urine Cytology / T.Shioya et al. / p270~270
  • 12.Prospects of Application of Monoclonal Antibodies for Diagnostic Cytology With Special Reference to Cytological Diagnosis of Leukemia and Malignant Lymphoma / K.Kikuchi et al. / p270~270
  • Panel Discussion 6 Ways of Maintenance Chemotherapy for Cancer / / p271~273
  • 1.Evaluation of 5000 Leukocyte Differential for Remission Maintenance Chemotherapy and Early Diagnosis of Relapse in Acute Leukemia / H.Shibata et al. / p271~271
  • 2.Adjuvant Chemotherapy after Surgery of Advanced Gastric Cancer / S.Hirose et al. / p271~271
  • 3.Evaluation of Postoperative Adjuvant Chemotherapy with FT-207 for Gastric Cancer / T.Tanaka et al. / p271~271
  • 4.Not Received / /
  • 5.The Role of Prolonged Surgical Adjuvant Chemotherapy in Cancer of the Colon and Rectum / T.Kato et al. / p272~272
  • 6.The Value of Maintenance Therapy in Disseminated Testicular Cancer / T.Miki et al. / p272~272
  • 7.Maintenance Chemotherapy with L-PAM for Ovarian Cancer after Combined Modality with CAPF and Second-Look Operation / J.Inagaki et al. / p272~272
  • 8.Study on the Effect of Classification and Adjuvant Chemotherapy for Cervical Carcinoma / T.Maeda et al. / p273~273
  • 9.The Role of Maintenance Chemotherapies with Malignant Brain Tumors / H.Yamamoto et al. / p273~273
  • Panel Discussion 7 Spontaneous Regression of Cancer / / p274~275
  • 1.A Case of Complete Remission of Carcinomatous Peritonitis / T.Yamada et al. / p274~274
  • 2.A Case of Spontaneous Regression of Pulmonary Metastases of Renal Cell Carcinoma / M.Tsuruta et al. / p274~274
  • 3.Spontaneous Regression in Neuroblastoma / J.Uchino et al. / p274~274
  • 4.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (IX) -On Local Lymphocyte Infiltration and Immunological Alteration of Long Survival Cases of Cancer Patients / S.Nakagawa et al. / p275~275
  • Panel Discussion 8 Role of Radiotherapy in Multidisciplinary Treatment for Cancer / / p276~281
  • 1.The Role of Radiotherapy for Malignant Brain Tumors in Multidisciplinary Therapy / H.Yamamoto et al. / p276~276
  • 2.Combined Modality Treatment with Radiation Therapy and Chemotherapy in Localized Cancer in the Head and Neck / N.Masaki et al. / p276~276
  • 3.Availability of Combination Therapy Using Operation with Irradiation in the Esophageal Cancer / M.Ikeda et al. / p276~276
  • 4.Significance of Radiation Therapy in Multidisciplinary Treatment for Esophageal Cancer / K.Morita et al. / p277~277
  • 5.Radiotherapy for Carcinoma of the Lung / Y.Takegawa et al. / p277~277
  • 6.Postoperative Radiation Therapy for Carcinoma of the Gallbladder and Biliary Tract / Y.Ogura et al. / p277~277
  • 7.The Role of Fast Neutron Radiotherapy in the Multi-modal Treatment of Osteosarcoma / N.Takada et al. / p278~278
  • 8.The Role of Radiotherapy on the Management of the Malignant Lymphoma / H.Niibe et al. / p278~278
  • 8'.Contribution of the Radiotherapy in the Treatment for Breast Cancer / T.Okawa et al. / p278~278
  • 8''.The Role of Radiotherapy in Multimodal Treatment for Breast Cancer / Y.Nakada et al. / p279~279
  • 8'''.Role of Radiotherapy in Multidisciplinary Treatment for Esophageal Carcinoma / S.Onoda et al. / p279~279
  • 8''''.Radiotherapy in the Multidisciplinary Treatment for Esophageal Carcinoma / T.Iizuka / p279~279
  • 9.The Role of Radiotherapy in the Treatment of Ovarian Cancer / J.Umezu et al. / p280~280
  • 9'.The Role of Radiotherapy in the Combination Treatment for Carcinoma of the Uterine Cervix / T.Arai et al. / p280~280
  • 9''.The Role of Radiation Therapy in the Treatment for Nonseminomatous Germinal Tumors of the Testis / M.Miki et al. / p280~280
  • 9'''.Evaluation of Radiation Therapy for Small Cell Lung Cancer in Randomized Study / R.Arai et al. / p281~281
  • Panel Discussion 9 Laser Therapy for Cancer / / p282~284
  • 1.CO₂ Laser Therapy of Intraepithelial Neoplasias of Cervix,Vulva,and Vagina / N.Tsukamoto et al. / p282~282
  • 2.Laser Surgery and FAR for Advanced Cancer of the Mesopharynx / T.Yoshida et al. / p282~282
  • 3.Transendoscopic Nd-YAG Laser Treatment of Lung Cancer / K.Oho et al. / p282~282
  • 4.Transurethal Laser Surgery for Bladder Tumor / K.Okada et al. / p283~283
  • 5.Endoscopic Laser Treatment for Tumors of the Gastrointestinal Tract / H.Sugiura et al. / p283~283
  • 6.Endoscopic Laser Treatment of Gastrointestinal Cancer / M.Maruyama et al. / p283~283
  • 7.Experimental and Clinical Studies of HPD Photoradiaton Therapy for Upper Gastrointestinal Cancer / S.Mimura et al. / p284~284
  • 8.Photoradiation Therapy of Superficial Bladder Tumors and CIS / H. Hisazumi et al. / p284~284
  • 9.Photodynamic Therapy for Malignant Tumors, Especially Lung Cancer, with Hematoporphyrin Derivative and Laser Beam / H. Kato et al. / p284~284
  • Panel Discussion 10 Intraarterial Infusion Chemotherapy / / p285~290
  • 1.Intraarterial Infusion Therapy of the Stage III Breast Cancer / T.Ueda et al. / p285~285
  • 2.Characteristics and Limitation of Intra-arterial lnfusion Cancer Chemotherapy with Special Reference to Intra-aortic Infusion / K.Yoshikawa et al. / p285~285
  • 3.Constant Intra-arterial Infusion Chemotherapy for Cancer Patients with Peritoneal Metastases / M.Sato et al. / p285~285
  • 4.Technical Improvement in Transcatheter Intraarterial Chemotherapy / K.Hiramatsu et al. / p286~286
  • 5.Intra-arterial Infusion Chemotherapy Using an Implantable Pump for the Treatment of Cancers of Liver and Pancreas / T.Miura et al. / p286~286
  • 5'.Low Dose-intermittent Intraarterial Infusion Chemotherapy of MFC Using a Sub-cutaneously Implanted Silicone Reservoir / Y. Arai et al. / p286~286
  • 5''.Infusion Anti-cancer Chemotherapy through a Directly Wedged Arterial Catheter / M.Takahashi et al. / p287~287
  • 6.Hemodynamic Study during Intra-arterial Infusion Chemotherapy of Hepatic Cancer--Examination by Kr-81m,Xe-133,Tc-99m-MAA via the Hepatic Artery / Y.Sasaki et al. / p287~287
  • 7.Arterial Infusion Chemotherapy with Angiotensin 2 for Advanced Gastric Carcinoma / T.Konishi et al. / p287~287
  • 7'.Effects and Methods of Preoperative Chemotherapy in the Treatment of Pediatric Malignant Solid Tumors--With Emphasis on Continuous Intra-arterial Infusion of PGE / S.Ogita et al. / p288~288
  • 7".Intraarterial Chemotherapy with Nor-Adrenalin The Third Report Supperselect Injection / T.Sato et al. / p288~288
  • 8.Antitumor Effects of Intra-arterially Infused Biodegradable Microspheres Containing Mitomycin C / S.Fujimoto et al. / p288~288
  • 8'.Effect of Arterial Administration of High-molecular weight Anticancer Agent SMANCS with Lipid Lymphographic Agent on Various Malignant Solid Tumors / T.Konno et al. / p288~289
  • 8".Transcatheter Arterial Chemo-Embolizatian for Locally Advanced Breast Cancer / Y.Takatsuka et al. / p289~289
  • 9."Two Route Infusion Chemotherapy" for Human Primary and Secondary Liver Cancer / R. Abe et al. / p289~289
  • 9'.Intra-arterial Infusion Chemotherapy for Bladder Cancer with a Simultaneous Use of Direct Hemoperfusion (DHP)--Adsorption Capacity of Cis-Diammine Dichloro Platinum (CDDP) by DHP / T. Shimizu et al. / p290~290
  • 9". Double Channel Chemotherapy with Intra-arterial Infusion of DDP and Concurrent Intra-venous Infusion of STS (Sodium Thiosulfate) for Bladder Cancer / H.Sekine et al. / p290~290
  • 10.Pelvic Isolation Perfusion Hyperthermia / I.Yokoyama et al. / p290~290
  • Panel Discussion 11 Parenteral Nutrition in Cancer Therapy / / p291~293
  • 1.Intravenous Nutrition for Cancer Therapy / T.Itakura et al. / p291~291
  • 2.A Study on Combined Chemo-therapy of Intra-venous Hyperalimentation for Advanced Gastro-intestinal Cancer / T.Yamasaki et al. / p291~291
  • 3.Effect of Postoperative Total Parenteral Nutrition (TPN) as an Adjunct to Gastrectomy for Advanced Gastric Carcinoma / K.Hioki et al. / p291~291
  • 4.Effect of Intravenous Hyperalimentation on Preoperative Radiation Therapy in the Patients with Esophageal Carcinoma / Y.Matsubara et al. / p292~292
  • 5.Postoperative Combined Therapies for the Esophageal Carcinomas under the Support of Total Parenteral Nutrition (TPN) / T.Nishihira et al. / p292~292
  • 6.Effects and Problems of Parental Hyperalimentation in Cancer Therapy--Evaluation from the Surgical Standpoint / K.Terabe et al. / p292~292
  • 7.Usefulness of TPN in the Cancer Treatment / T.Sugita et al. / p293~293
  • 8.The Treatment of Advanced Cancer with Amino Acid Imbalance / Y.Kawaura et al. / p293~293
  • 9.Methionine and Cystine Free Amino-acid Imbalance as an Adjunct to Cancer Chem-otherapy / N.Goseki et al. / p293~293
  • Panel Discussion 12 Alteration of Drug Type of Anti-cancer Agents / / p294~298
  • 1.Phase II Study of Sustained Release Granules of Tegafur (SF-SP) / H.Satou et al. / p294~294
  • 2.Comparison between Blood and Lymphatic Transport of Tegafur--Special Reference to Changes of Drug Type / H.Hanaue et al. / p294~294
  • 3.Solubilization of Various Anticancer Agents in Lipid Contract Medium and Pharmacological Study / H.Maeda et al. / p294~294
  • 4.Utility of Albumin Microspheres Containing Antitumor Agents in Cancer Chemotherapy / Y.Morimoto et al. / p295~295
  • 5.Targeted Cancer Chemotherapy by Fat-emulsified 5FU and by Mitomycin C Adsorbed to Activated Carbon Particle / A.Hagiwara et al. / p295~295
  • 6.New Type of Thrombotic Materials / A.Sugitachi et al. / p295~295
  • 7.Clinical Evaluation of Tubed Solidified Bleomycin (TS-BLM) for Microscopical Treatment in the Surgery of Cancer of the Esophagus / H.Watanabe / p296~296
  • 8.Studies on the Injected Therapy of PANa-oil-bleomycin in Nonresectable Esophageal Carcinoma (Comparative Study of the Resected Specimens) / Y.Kataba et al. / p296~296
  • 9.Clinical Trial of Local Chemotherapy in Inoperable Pancreatic Cancer,Gall Bladder Cancer and Hepatoma / M.Nakamura et al. / p296~296
  • 10.Microencapsules as a Means of Targeted Cancer Chemotherapy / T.Kato et al. / p297~297
  • 11.Treatment of Prostatic Cancer with LH-RH Agonist(leuprolide)-copolymer Composite / H.Yamanaka et al. / p297~297
  • 12.Developmental and Therapeutic Application of Intravesical Stick as Local Chemotherapy for Bladder Cancer / Y.Matsumoto / p297~297
  • 13.Fundamental and Clinical Study of ADR Ointment / M.Fukuda et al. / p298~298
  • Panel Discussion 13 Interferons / / p299~303
  • 1.Clinical Study of Human Fibroblast Interferon(HFIF)and Human Lymphoblastoid Interferon(HLBI) / N.Usui et al. / p299~299
  • 2.Treatment of Hematological Malignancies with Interferons / R.Ohno et al. / p299~299
  • 3.Interferon Treatment on Patient with Advanced Cancer / H.Mugitani et al. / p299~299
  • 4.Clinical Evaluation of Human Lymphoblastoid Interferon(HLBI)in the Treatment of Hepatic Tumor / N.Yoshioka et al. / p300~300
  • 5.Antitumor Effect of Human Fibroblast Interferon(IFN-β)on Patient with Hepatocellular Carcinoma(HCC) / T.Okai et al. / p300~300
  • 6.Early Phase II of γ IFN-αA(Ro22-8181)on the Patients with Urogenital Cancer / J.Yoshimoto et al. / p300~300
  • 7.Clinical Evaluation of the Treatment with Interferon(IFN-α)Followed by OK-432 on the Advanced Renal Cell Carcinoma / M.Murai et al. / p301~301
  • 8.Interferon Therapy for Malignant Brain Tumor Patients / S.Ueda et al. / p301~301
  • 9.Combination Therapy of Interferon and Radiation to Malignant Brain Tumors / T.Arai et al. / p301~301
  • 10.Preliminary Study of Children's Brain Tumors Treated by Interferon(IFN-α)and Radiation / T.Miyoshi et al. / p302~302
  • 11.Bronchial Arterial Infusion(BAI)Therapy of IFN-β to Lung Cancer / H.Masuda et al. / p302~302
  • 12.Clinical and Experimental Study on Enhancing Effect of IFN-α on Natural Killer(NK)Cell Activity / M.Hayakawa et al. / p302~302
  • 13.Effect of Various Types/Sources of Interferons on Cytotoxic Activity of Lymphocyte / H.Dozono et al. / p303~303
  • 14.Modulation of 5-Fu Induced Toxicity in C3H/He Mice with Interferon or with the Interferon Inducers / M.Akimoto et al. / p303~303
  • Panel Discussion 14 Anti-cancer Agents of Anthracycline Lineage / / p304~306
  • 1.Pharmacokinetics of 4'-Epiadriamycin and 4'-O-Tetrahydropyranyl-Adriamycin / H.Fujita et al. / p304~304
  • 2.Clinical Comparative Study of THP-Adriamycin and 4'-Epiadriamycin / K.Ikeda et al. / p304~304
  • 3.Comparative Studies of Cardiomyopathy Induced in Rabbits by Various Anthracyclines and Anthraquinone / N.Domae et al. / p304~304
  • 4.A Comparative Study of 4'-Epidoxorubicin and Doxorubicin Cardiotoxicities / T.Suzuki et al. / p305~305
  • 5.Clinical Effect of THP-ADM on Acute Leukemia and Malignant Lymphoma / Y.Tani et al. / p305~305
  • 6.Aclarubicin(ACR)and a Combination of ACR,Vincristine,Cyclophosphamide and Prednisolone in the Treatment of Multiple Myeloma / T.Sezaki et al. / p305~305
  • 7.Treatment with ADR and THP-ADR for Non Small Cell Lung Cancer--Including Randomized Trial / S.Negoro et al. / p306~306
  • 8.Clinical Effect of 4'-O-Tetrahydropyranyl-Adriamycin(THP-ADM)on Gynecological Malignant Diseases / M.Suzuki et al. / p306~306
  • 9.Antitumor Effects of Anthracyclines and Anthraquinone on Advanced Breast Cancer Patients / M.Kitamura et al. / p306~306
  • Panel Discussion 15 Fluorinated Pyrimidine Derivatives / / p307~308
  • 1.Influence of Uracil,Thymine and Thymidine on the Pharmacokinetics of Various Fluoropyrimidines--With special Reference to UFT / H.Fujita et al. / p307~307
  • 2.Recent Advance of Gastrointestinal Cancer Chemotherapy with Oral Administration of Fluoropyrimidines / M.Yamamura et al. / p307~307
  • 3.Enzymatic Activation of Tegafur and 5'-deoxy-5-fluorouridine(5'-DFUR)to 5-fluorouracil(5Fu)in Human Tumor Tissue / Y.Hara et al. / p307~307
  • 4.Effect of Fluorinated Pyrimidine Derivatives against Primary Lung Cancer and Metastatic Pulmonary Tumor / E.Shimizu et al. / p308~308
  • 5.Comparative Effect and Toxicity of Fluorinated Pyrimidine Derivatives--With Special Reference to 5'-deoxy-5-fluorouridine(5'-DFUR) / J.Ota et al. / p308~308
  • 6.Clinical Trials of Two Derivatives of FUDR,2'-Deoxy-3',5'-o-acethyl-5-fluoro-3-(3-methylbenzoyl)uridine(FF-705)and 5-Fluoro-3(3,4-methylene-dioxybensoyl)-2'-deoxy-β-uridine(TK-117) / M.Matsumoto / p308~308
  • Panel Discussion 16 Podophyllotoxin Derivatives / / p309~312
  • 1.The Mechanism of Action of VP-16 / Y.Izumi et al. / p309~309
  • 2.A Phase I Study of VP-16-213(VP)by a Single and 5-Day Infusion / M.Yokoyama et al. / p309~309
  • 3.Phase I Study on Etoposide(NK 171),a Semisynthetic Derivative of Podophyllotoxin / K.Yamada et al. / p309~309
  • 4.A Phase II Trial of VP-16-213 in Hematologic Malignancy / K.Sampi et al. / p310~310
  • 5.Phase II Study of VP-16 / I.Tanaka et al. / p310~310
  • 6.A Clinical Trial of Etoposide on Adult T-cell Leukemia/Lymphoma(ATLL)and Other Lymphoid Malignancies / M.Matsumoto / p310~310
  • 7.Phase II Trial of VP16 in Far Advanced Lung Cancer / S.Yoneda et al. / p311~311
  • 8.Clinical Experience of Etoposide(NK171)in Patients with Bronchogenic Carcinoma and Metastatic Pulmonary Tumors / K.Eguchi et al. / p311~311
  • 9.Treatment with Etoposide to Pts with Far Advanced Lung Cancer / M.Takada et al. / p311~311
  • 10.Combination Chemotherapy of Small Cell Lung Cancer with Vincristine,Etoposide and Cyclophosphamide / K.Aiba et al. / p312~312
  • Panel Discussion 17 Cisplatin / / p313~316
  • 1.Preclinical and Clinical Studies on Cisplatin Treatment for Head and Neck Cancer / Y.Inuyama et al. / p313~313
  • 2.Cis-Dichlorodiammineplatinum(II)in Lung Cancer / N.Kodama et al. / p313~313
  • 3.Effects of CDDP Administration on Treatment of Esophageal Cancer / Y.Koide et al. / p313~313
  • 4.2 Channel Infusion Therapy of Cisplatin Using Balloon Catheter for Primary Liver Cancer / S.Onohara et al. / p314~314
  • 5.Combined Cisplatin against Malignant Ovarian Tumors / A.Tsunawaki et al. / p314~314
  • 6.Treatment of Advanced Testicular Tumors with BVP Regimen / I.Fukui et al. / p314~314
  • 7.Pre-operative Cisplatin Chemotherapy in Osteosarcoma / S.Takeyama et al. / p315~315
  • 8.Phase II Study of Cis-Dichlorodiammineplatinum(II)(CDDP)in Advanced Malignant Lymphomas / T.Ibuka et al. / p315~315
  • 9.Evaluation of Cisplatin in Children with Advanced Malignant Tumors / A.Toyosaka et al. / p315~315
  • 10.Efficacy Study of Cisplatin Based Chemotherapy in Bronchogenic Carcinoma / N.Hara et al. / p316~316
  • General Lecture 1.Effects of Intravenous Hyperalimentation(IVH)on Tumor Growth and Tumor Response to P-Aminobenzoic Acid-N-Xyloside Sodium Salt(k-247) / K.Kishi et al. / p317~317
  • General Lecture 2.Effect of Total Parenteral Nutrition(TPN)as an adjunct to Patients with Total Gastrectomy and Proximal Gastrectomy for Gastric Cancer and Patients with Recurrence Gastric Cancer / O.Kojima et al. / p317~317
  • General Lecture 3.Effects of Intravenous Hyperalimentation Adjunct to the Anticancer Chemotherapy / M.Kimoto et al. / p317~317
  • General Lecture 4.Effect of Preoperative Intravenous Hyperalimentation(IVH)on Nutritional Status and Immune Response in Esophageal Cancer Patients / T.Saito et al. / p318~318
  • General Lecture 5.Postoperative Management of Advanced Cancer by IVH with Low Dose Heparin / K.Tari et al. / p318~318
  • General Lecture 6.Preparation of Anti-Hela Cell Monoclonal Antibody by Cell Fusion / S.Sekiya et al. / p318~318
  • General Lecture 7.Serum AFP Subfractions in Patients with Primary Hepatoma or Hepatic Metastasis of Gastric Cancer / T.Ishiguro et al. / p319~319
  • General Lecture 8.Clinicopathological Study of 36 Cases of Alpha-fetoprotein Positive Gastric Cancer / A.Usui et al. / p319~319
  • General Lecture 9.Clinical Value of Basic Fetoprotein in Malignant Digestive Diseases / Y.Kanda et al. / p319~319
  • General Lecture 10.Evaluation of Prostate-specific Antigen in Prostate Cancer / T.Takeuchi et al. / p320~320
  • General Lecture 11.Antibody Response against CALLA in Children with Acute Lymphoblastic Leukemia(ALL)Receiving Specific Active Immunotherapy / E.Azuma et al. / p320~320
  • General Lecture 12.Evaluation of a Pancreatic Oncofetal Antigen(POA)in Patients with Carcinoma and Benign Disease of the Pancreas / S.Hishinuma et al. / p320~320
  • General Lecture 13.Evaluation of Tumor Markers for Carcinoma of the Pancreas / N.Kuno et al. / p321~321
  • General Lecture 14.Clinical Evaluation of Serum Tissue Polypeptide Antigen(TPA)Concentration in Patients with Malignancy of the Digestive System / H.Sakahara et al. / p321~321
  • General Lecture 15.A Study of Serum TPA in Patients with Gastric Cancer / Y.Otani et al. / p321~321
  • General Lecture 16.Gastric Cancer and Tumor Markers / Y.Uehara et al. / p322~322
  • General Lecture 17.Studies on Tissue Polypeptide Antigen in Patients with Gastric Cancer / K.Sakamoto et al. / p322~322
  • General Lecture 18.Comparative Study of Serum Levels of TPA, CEA and Ferritin on Colorectal Cancer Patients / Y.Takata et al. / p322~322
  • General Lecture 19.Tissue Polypeptide Antigen in Breast Cancer / T.Nomizu et al. / p323~323
  • General Lecture 20.Studies on Tissue Localization of Tumor-markers in Ovarian Tumors by Immunoperoxidase Method / T.Tanimura et al. / p323~323
  • General Lecture 21.Assessment of Diagnostic Efficacy of Plasma Tissue Polypeptide Antigen as a Tumor Marker--Comparison with Other Markers and Their Combined Use / D.Tsujino et al. / p323~323
  • General Lecture 22.Clinical Evaluation of a Serum Tissue Polypeptide Antigen(TPA)in Patients with Solid Cancer--In Comparison with Other Tumor Markers / J.Matsui et al. / p324~324
  • General Lecture 23.Hematoporphyrin Derivative(HpD)Uptake and Photoinactivation in in vitro Cultivated Human Bladder Cancer Cells(KK-47) / O.Ueki et al. / p324~324
  • General Lecture 24.Fundamental Studies of Photoradiation Therapy on Human Cancer Cells in vitro in the Presence of Hematoporphyrin / T.Kuwahara et al. / p324~324
  • General Lecture 25.Photoradiation Therapy(PRT)for Experimental Tumor Using Excimer Dye Laser / M.Otawa et al. / p325~325
  • General Lecture 26.Thermal Considerations on Laser Photodynamic Treatment / M.Yonekawa et al. / p325~325
  • General Lecture 27.Optical Properties of Malignant Patients' Blood under Ar-Laser Line at DC Magnetic Field / H.Hayashi et al. / p325~325
  • General Lecture 28.Clinical Studies on Laser Endoscopy for Treatment of Superficial Esophageal Cancer:Argon-Dye Laser in Combination with HpD / T.Hirashima et al. / p326~326
  • General Lecture 29.Endoscopic Photoradiation Therapy for Esophageal Cancer / N.Okushima et al. / p326~326
  • General Lecture 30.Photoradiation Therapy in the Treatment of Respiratory Malignancy / K.Furuse et al. / p326~326
  • General Lecture 31.Pathological Examination of Resected Specimens of Central Type Early Squamous Cell Carcinoma after Laser Treatment / R.Amemiya et al. / p327~327
  • General Lecture 32.Photoradiation Therapy of Lung Cancer by Argon Laser / K.Fujioka et al. / p327~327
  • General Lecture 33.Combined Therapy of Laser Radiation and Immunochemotherapy for Cancerous Stenosis / S.Akazawa et al. / p327~327
  • General Lecture 34.Application of Laser Surgery for Malignant Tumor of Digestive System / F.Sano et al. / p328~328
  • General Lecture 35.Fundamental and Clinical Studies of Photoradiation Therapy in Gynecological Malignancies / T.kasai et al. / p328~328
  • General Lecture 36.Treatment of Neoplasms in the Uterine Cervix by CO₂-laser / K.Sakamoto et al. / p328~328
  • General Lecture 37.Enhancement by Hyperthermia of the in vitro Cytotoxicity of Anticancer Drugs on Human Lung Epidermoid Carcinoma Cells / T.Seto et al. / p329~329
  • General Lecture 38.Effect of Hyperthermia on KK-47 Human Bladder Cancer Cells Hetero-transplanted in Nude Mice / Y.Saitoh et al. / p329~329
  • General Lecture 39.Experimental Studies of Regional Hyperthermia on MH134 Tumor under Various Conditions of Heating / Y.Matsuzaki et al. / p329~329
  • General Lecture 40.Hyperthermia for Experimental Colon Carcinoma of Dogs / T.Kamano et al. / p330~330
  • General Lecture 41.Fundamental Study of RF Hyperthermia / A.Sugiyama et al. / p330~330
  • General Lecture 42.Regional Hyperthermo-chemotherapy with in-vivo Isolated Liver Perfusion for the Treatment of Liver Tumors in the Rats / M.Miyazaki et al. / p330~330
  • General Lecture 43.Radio-chemo-thermal Treatment for Advanced Hepato-choledoco-pancreatic Tumors / T.Yamashita et al. / p331~331
  • General Lecture 44.Hyperthermo-chemotherapy for Peritoneal Dissemination of Cancer by Peritoneal Perfusion / N.Mizuguchi et al. / p331~331
  • General Lecture 45.Combination Thermotherapy of Systemic Hyperthermia Plus Local R.F.Heating / N.Kato et al. / p331~331
  • General Lecture 46.Studies on Preoperative Combined Therapy with Hyperthermia for Esophageal Cancer / A.Hanaoka et al. / p332~332
  • General Lecture 47.The Application of Induction Heating in Lesional Hyperthermia in Combination with Ferromagnetic Microembolization(FME) / M.Sako et al. / p332~332
  • General Lecture 48.Total Body Hyperthermia by Use of V-A By-pass Extracorporeal Circulation / H.Kawahara et al. / p332~332
  • General Lecture 49.Clinical Study for Local Hyperthermia / M.Tsumura et al. / p333~333
  • General Lecture 50.WHO Cancer Pain Relief Programme--Introduction of WHO Draft Interim Guideline and Its Field Testing / F.Takeda / p333~333
  • General Lecture 51.Analgesic Effect of Calcitonin on Patients with Bone Metastases of Breast Cancer / M.Kimura et al. / p333~333
  • General Lecture 52.Particular Aspects of Terminal Care in the Patients of Head and Neck Cancers / I.Ono et al. / p334~334
  • General Lecture 53.A New Treatment Method for Advanced Head and Neck Cancers / H.Takahashi et al. / p334~334
  • General Lecture 54.Mass Screening for Breast Cancer:Examination Rate and Detection Rate by Age Groups / N.Ueda et al. / p334~334
  • General Lecture 55.Comparative Study of the Mass Screening for Breast Cancer between Two Cities Located in the Sea Shore and Inland Area / R.Abe et al. / p335~335
  • General Lecture 56.The Process and Project of Mass Screening for Breast Cancer in Miyagi Prefecture / K.Yoshida et al / p335~335
  • General Lecture 57.The Breast Cancer Screening Survey in Kanagawa Prefecture(The Third Report) / H.Takemura et al. / p335~335
  • General Lecture 58.The Breast Cancer Screening Survey in Yokohama City(The Second Report) / T.Suda et al. / p336~336
  • General Lecture 59.Five Years Experience with Mass Screening for Thyroid Cancer / M.Tsuyuguchi et al. / p336~336
  • General Lecture 60.Mass Screening for Colorectal Cancer Using Occult Fecal Blood Testing / J.Ota et al / p336~336
  • General Lecture 61.Mass Screening of Neuroblastoma in Infancy / T.Takeda et al. / p337~337
  • General Lecture 62.Colposcopic Findings of Pregnant Women / T.Horii et al. / p337~337
  • General Lecture 63.Pre-operative Diagnosis for Stage II Endometrial Carcinoma Using Endocervical Conization / K.Fukuda et al. / p337~337
  • General Lecture 64.Determination of Cancer Residue after Conization and Selection of Follow up Cases / Y.Sakaguchi et al. / p338~338
  • General Lecture 65.Preoperative Diagnosis for Cervical Carcinoma by Using Punch Biopsy ,Cytology and Colposcopic Findings / H.Iwasaki et al. / p338~338
  • General Lecture 66.Evaluation of Biopsy for Choriocarcinoma / T.Tanaka et al. / p338~338
  • General Lecture 67.Gynecological Application of the Deep Body Thermometer / M.Sato et al. / p339~339
  • General Lecture 68.In vivo Measurement of Electrical Bio-impedance on Breast Tumors / K.Nishimoto et al. / p339~339
  • General Lecture 69.Biopsy for Breast Cancer / F.Takaekoh et al. / p339~339
  • General Lecture 70.Microcalcification Related to Blunt Duct Adenosis of the Breast / M.Hiratsuka et al. / p340~340
  • General Lecture 71.The Parenchymal Patterns of Breast as Risk Factors for Breast Cancer / T.Majima et al. / p340~340
  • General Lecture 72.Development of Contact-Micro-Cystoscopy The First Report: Observation of the Bladder Epithelium with Contact-Micro-Colpohysteroscope / M.Nakao et al. / p340~340
  • General Lecture 73.Brushing Cytology in Renal Pelvic and Ureteral Tumors / T.Okano et al. / p341~341
  • General Lecture 74.Multiple Mucosal Biopsy for Bladder Carcinoma / M.Igawa et al. / p341~341
  • General Lecture 75.Hepatocellular Carcinoma with Concomitant Obstructive Jaundice of 17-year-old Male--A Case Report / H.Kohno et al. / p341~341
  • General Lecture 76.An Experience of Therapy for Leiomyosarcoma of the Retroperitoneal Cavity / H.Fukasawa et al. / p342~342
  • General Lecture 77.Pregnancy Following Removal and Chemotherapy of Ovarian Embryonal Carcinoma(Higuchi-Kato)Group C(Mixed Germ Cell Tumor) / J.Saito et al. / p342~342
  • General Lecture 78.Carcinoma in situ of the Vulva / T.Saito et al. / p342~342
  • General Lecture 79.Endometrial Stromatosis--A Case Report / I.Shiozawa et al. / p343~343
  • General Lecture 80.A Case of Adenoid Cystic Carcinoma Arising from Bartholin's Gland--A Case Report and Review of Literatures / T.Sugiyama et al. / p343~343
  • General Lecture 81.The Effects of Lentinan Injection on the Adrenalectomized Rats Bearing DMBA-induced Mammary Tumor and Human Mammary Cancer / A.Kosaka et al. / p343~343
  • General Lecture 82.Enhancement of Immunocompetence of Local Lymph Nodes by Local Infusion of PSK / H.Funahashi et al. / p344~344
  • General Lecture 83.Anticarcinogenic Actions of Water-soluble and Alcohol-insoluble Fractions from Culture Medium of Lentinus Edodes Mycelia / K.Tazawa et al. / p344~344
  • General Lecture 84.Immunotherapy by Using N-CWS in Postoperative Gastric Cancer Patients / S.Koyama et al. / p344~344
  • General Lecture 85.The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli(S.S.M.)--Report V / K.Fujita et al. / p345~345
  • General Lecture 86.In vitro Antiproliferative Activity of Interferon against Bladder Carcinoma Cell Lines / T.Nasu et al. / p345~345
  • General Lecture 87.Changes of NK and ADCC Activities in Cancer Patients Treated with Recombinant Human Leukocyte Interferon A / K.Domoto et al. / p345~345
  • General Lecture 88.Inhibitory Effect of IFN-Cyclophosphamide Therapy on the Growth of Tumor Trans-planted in Nude Mice / M.Takada et al. / p346~346
  • General Lecture 89.Effect of Interferon in the Treatment of Malignant Tumors / O.Nakamura et al. / p346~346
  • General Lecture 90.Increased Cytotoxicity Effects of Various Anticancer Drugs by α-interferon(HLBI)on Human Tumor Xenografts in Nude Mice / Y.Nosoh et al. / p346~346
  • General Lecture 91.Clinical Evaluation of HLBI(Human Lymphoblastoid Interferon)on the Treatment of Multiple Myeloma / Y.Matsuura et al. / p347~347
  • General Lecture 92.Chemotherapy of Renal Cell Carcinoma 4.Interferon / Y.Satomi et al. / p347~347
  • General Lecture 93.HLBI(Human Lymphoblastoid Interferon)Therapy on Metastatic Lesion of Renal Cell Carcinoma / H.Natsume et al. / p347~347
  • General Lecture 94.Clinical Evaluation of Interferon-β and-α on the Treatment of Thyroid Cancer / I.Nagata et al. / p348~348
  • General Lecture 95.Multidisciplinary Treatment with Interferon Inducer,Ge-132,in Our Department / H.Fukazawa et al. / p348~348
  • General Lecture 96.Pharmacologic Studies of Cisplatin / M.Sawada et al. / p348~348
  • General Lecture 97.Efficacy of Cisplatin (IP)+Sodium Thiosulfate(SC)on Peritonitis Carcinomatosa of Nude Mice Transplanted Human Gastric Cancer / S.Takao et al. / p349~349
  • General Lecture 98.Clinical and Fundamental Analysis of Cis-Diamminedichloroplatinum(II)(CDDP)Therapy by Measuring Tissue CDDP Concentration / S.Kodama et al. / p349~349
  • General Lecture 99.Analysis of Effect of C-DDP on Kinetic Change of DNA & RNA in Cultured Cells / T.Ishibashi et al. / p349~349
  • General Lecture 100.Clinical Study of Cis-Platinum 1.Clinical Pharmacokinetics and Toxicities of Cis-Platinum in Children / K.Sasaki et al. / p350~350
  • General Lecture 101.Ultrastructural Observation on DDP Drug Action to Urological Cancers in Nude Mice / K.Yoshida et al. / p350~350
  • General Lecture 102.Intraperitoneal Administration of Cisplatin and Protease Inhibitor for Peritonitis Carci-nomatosa in the Mice / T.Kurokawa et al. / p350~350
  • General Lecture 103.Cytocidal Effect of CDDP on Malignant Brain Tumor Cells and Pharmacokinetics / Y.Fujioka et al. / p351~351
  • General Lecture 104.Pharmacokinetic Study in Combination Therapy with CDDP and PEP--Interaction with Plasma Protein / M.Fujii et al. / p351~351
  • General Lecture 105.Anti-tumor Effects and Plasma Platinum Levels in the Combination Therapy of Cis-platinum with Thiosulfate / M.Maeta et al. / p351~351
  • General Lecture 106.Combined Chemotherapy with Cisplatin and Bleomycin for Malignant Tumor of the Chest / Y.Saitoh et al. / p352~352
  • General Lecture 107.CMAF(Cis-platinum Combined with Mitomycin C, Adriamycin and 5-FU) in the Treatment of Lung Cancer and Non-epithelial Cell Carcinomas / T.Tatsumura et al. / p352~352
  • General Lecture 108.Clinical Response and Toxicity with cis-Dichlorodiammineplatinum(II)in Primary and Metastatic Lung Cancer Patients / K.Tominaga et al. / p352~352
  • General Lecture 109.Clinical Study of Combination Chemotherapy with CDDP,PEP,MMC(PPM Therapy)and CDDP,5-FU,MMC(PFM Therapy)for Non-small Cell Lung Cancer / T.Goto et al. / p353~353
  • General Lecture 110.Cisplatin and Bleomycin in the Treatment of Squamous Cell Carcinoma of the Lung / A.Yokoyama et al. / p353~353
  • General Lecture 111.TPA,CEA and IAP Levels in Gynecological Cancer / S.Saitoh et al. / p353~353
  • General Lecture 112.Clinical Significance of Tissue Polypeptide Antigen in Patients with Cervical Cancer / Y.Yanagawa et al. / p354~354
  • General Lecture 113.Clinical Significance of Tissue Polypeptide Antigen(TPA)in Gynecologic Malignant Diseases / K.Kato et al. / p354~354
  • General Lecture 114.Multiple Tumor Markers in Patients with Gynecologic Malignancies / Y.Inoue et al. / p354~354
  • General Lecture 115.Study of Tumor Markers(hCG,SP1,PP5,TPA)in Trophoblastic Disease / K.Isaka et al. / p355~355
  • General Lecture 116.Study on Immunotherapy and Immunodetection Using Anti-CEA Antibody in Gastro-intestinal Cancer / A.Ohashi et al. / p355~355
  • General Lecture 117.Immunohistochemical Detection of Carcinoembryonic Antigen in Benign Hyperplasia and Adenocarcinoma of the Prostate with Monoclonal Antibody / M.Ghazizadeh et al. / p355~355
  • General Lecture 118.Role of Plasma CEA Levels in Evaluating Breast Cancer Patient Status / K.Hisamatsu et al. / p356~356
  • General Lecture 119.Lung Cancers and Their Serum CEA Levels / M.Suyama et al. / p356~356
  • General Lecture 120.Differential Diagnosis of the Cases with Pleural Effusions / M.Ogino et al. / p356~356
  • General Lecture 121.Tissue Carcinoembryonic Antigen in Uterine Cervical Cancer / H.Kitagawa et al. / p357~357
  • General Lecture 122.A New Serological Diagnostic Method for Malignant Tumors of Germ Cell Origin / K.Higaki et al. / p357~357
  • General Lecture 123.Plasma Exchanges in Patients with Advanced Cancer:Reference to the Elimination of Serum Immunosuppressive Factors by Filtration / K.Nakanishi et al. / p357~357
  • General Lecture 124.Clinical Effects of Plasmapheresis for Recurrent Carcinoma of the Large Intestine / N.Azuma et al. / p358~358
  • General Lecture 125.Plasma Exchange for the Cancer-bearing Patients in Terminal Stage / T.Tani et al. / p358~358
  • General Lecture 126.Double Filtration Plasmapheresis in Patients with Renal Cell Cancer / A.Yamasaki et al. / p358~358
  • General Lecture 127.Selective Removal of Immunosuppressive Factors by Double Filtration Plasmapheresis(DFPP)in Cancer Patients / M.Miyazaki et al. / p359~359
  • General Lecture 128.Studies on the Host Immune Response in Rat during Induction of Bladder Tumors by BBN / Y.Ozaki et al. / p359~359
  • General Lecture 129.Leukocyte Migration Inhibition(LMI) of Murine Spleen Cells after Immunization with Tumor Cells 2.Assessment with LMI in Combination Therapy with a Non-specific Immunostimu-lant and a Chemotherapeutic Agent / T.Umeda et al. / p359~359
  • General Lecture 130.Direct Antitumor Activity of Biological Response Modifiers(B.R.M.)Proven by Our in vitro Sensitivity Test / T.Yanagawa et al. / p360~360
  • General Lecture 131.Effect of Organic Germanium Compound,GE-132 on NK Activity of Peripheral Blood Lymphocytes from Cancer Patients / J.Ohida et al. / p360~360
  • General Lecture 132.NK Cell Activity and Adjuvant Chemo-immuno Therapy of the Colorectal Carcinoma / T.Jo et al. / p360~360
  • General Lecture 133.Specific Active Immuno-chemotherapy with a Solublized Tumor Antigen / M.Kobayashi et al. / p361~361
  • General Lecture 134.Chemoimmunotherapy of Implanted Murine Bladder Cancer / H.Akaza et al. / p361~361
  • General Lecture 135.Immunochemotherapy against Human Malignant Brain Tumors Transplanted into Nude Mice / T.Hori et al. / p361~361
  • General Lecture 136.The Effect of Bestatin on Experimental Lingual Cancer / N.Akazawa et al. / p362~362
  • General Lecture 137.Anti-tumor Activity of Cimetidine / Y.Ito et al. / p362~362
  • General Lecture 138.The Effect of Cimetidine on NK Cell Activity and Responsiveness to PHA of PBL in Patients with Gynecologic Malignancies / Y.Kikuchi et al. / p362~362
  • General Lecture 139.Inpact of the Oral Administration of OK-432 and Nutritional Status on Antitumor Activity and Antimetastatic Effect in Regional Lymph Nodes in C3H/He Mice / Y.Nakajima et al. / p363~363
  • General Lecture 140.Immunological Studies of the Cervical Lymph Nodes in Oral Cancer Patients / Y.Ichikawa et al. / p363~363
  • General Lecture 141.Localization of Lymphocyte in Uterine Cervical Cancer / S.Shiraki et al. / p363~363
  • General Lecture 142.The Change of Electrophoretic Activity of Peripheral Lymphocytes in Cancer Patients (The Second Report) / T.Mori et al. / p364~364
  • General Lecture 143.Changes in the Electrophoretic Mobility of Lymphocytes in Cancer Patients and Its Clinical Significance / M.Maeno et al. / p364~364
  • General Lecture 144.Influences of Operative Intervention on NK Activity and the Effect of OK-432 Administration Evaluated by NK Activity Experimental Analysis Using Rat's Mammary Tumor(MRMT-1) / H.Oshita et al. / p364~364
  • General Lecture 145.Prophylactic Effect of OK-432 for Experimental Models of Peritoneal Carcinomatosis / T.Iijima et al. / p365~365
  • General Lecture 146.Augmentation of Natural Killer Activity of Abdominal Lymph Nodes in C3H/He Mice by the Oral Immunotherapy with OK-432 / M.Akimoto. / p365~365
  • General Lecture 147.Oral Administration of Streptococcal Preparation OK-432--Enhancement of Natural Killer(NK)Activity and Mitogen Response / Y.Nio et al. / p365~365
  • General Lecture 148.Study on Urogenital Cancer Immunotherapy with OK-432:Common Antigenicity between either Animal or Human Tumors and OK-432 / T.Fujioka et al. / p366~366
  • General Lecture 149.Effect of Intralymphatic Administration of OK-432 for Advanced Cancer / N.Takahashi et al. / p366~366
  • General Lecture 150.The Effect of OK-432 Preoperative Intratumoral Injection / A.Gouchi et al. / p366~366
  • General Lecture 151.Prognostic Significance of Massive Intratumoral Injection of OK 432 in Unresectable Cancer of the Pancreas / I.Mizuno et al. / p367~367
  • General Lecture 152.Intraperitoneal Administration of OK 432 to Gynecological Malignant Ascites / S.Honma et al. / p367~367
  • General Lecture 153.Effect of Immunotherapy Using OK 432 for Malignant Ovarian Tumor / T.Kano et al. / p367~367
  • General Lecture 154.Clinical Evaluation of the Su-PS Skin Reaction in Post-Operative Immunotherapy with OK-432 in Oral Cancer Patients / M.Odani et al. / p368~368
  • General Lecture 155.Clinical Value of Immunotherapy by Streptococcal Preparation OK-432 for Lung Cancer--Randomized Study / Y.Watanabe et al. / p368~368
  • General Lecture 156.Immunochemotherapy of Gastric and Colorectal Cancer-effect of Intradermal Injection of OK-432 / T.Kajitani et al. / p368~368
  • General Lecture 157.Effect of OK-432 on Bone Marrow Suppression Caused by Anti-cancer Chemotherapy / T.Tsurumi et al. / p369~369
  • General Lecture 158.The Postoperative Follow-up Study of Non-curative Gastric Resection Treated by Immunochemotherapy in Gastric Cancer / Y.Suda et al. / p369~369
  • General Lecture 159.Clinical Effect of Immunochemotherapy with K-247 on Stomach Cancer / K.Ogoshi et al. / p369~369
  • General Lecture 160.Adjuvant Immunochemotherapy for Patients with Stomach Cancer / K.Ogoshi et al. / p370~370
  • General Lecture 161.A Study of Combined Method with a Large Quantity of Uronase in the Case of Inoperative Gastric Cancer / T.Yamada et al. / p370~370
  • General Lecture 162.The Effect of Immuno-chemotherapy for Peritonitis Carcinomatosa / Y.Watanabe et al. / p370~370
  • General Lecture 163.Comparative Observation on Effective and Uneffective Cases Performed Specific Immunotherapy in Cancer Patients / K.Takashima et al. / p371~371
  • General Lecture 164.Study on Changes in Cellular Immune Reactivities in the Patients of Advanced Cervical Cancer after Treatment Part5 :Cellular Immune Reactivities in Recurrent or Dead Cases / K.Hasegawa et al. / p371~371
  • General Lecture 165.Study of Adverse Effects Induced by Combined Therapy of Cyclophosphamide(CPA)and PSK / Y.Yamamura et al. / p371~371
  • General Lecture 166.Effect of Cancer Immunotherapy and Reflection on Our Experience / T.Ohgane et al. / p372~372
  • General Lecture 167.Immunoadsorption of IgG or Its Complexes Using the Newly-devised Protein A Column / M.Sakita et al. / p372~372
  • General Lecture 168.The Cytotoxic Activity of Tumor Infiltrating Lymphocyte(TIL)and Its Application for Adoptive Immunotherapy / T. Hori et al. / p372~372
  • General Lecture 169.Transfer Factor Immunotherapy for Primary Lung Cancers / T.Fujisawa et al. / p373~373
  • General Lecture 170.Antitumor Effect of Schizophyllan(SPG)on Macrophage Activity / H.Itoh et al. / p373~373
  • General Lecture 171.Clinical Evaluation of SPG on Advanced Gastric Cancer / I.Nakao et al. / p373~373
  • General Lecture 172.Adjuvant Immunochemotherapy with SPG for Patients with Resectable Gastric Cancer / S.Fujimoto et al. / p374~374
  • General Lecture 173.Clinical Evaluation of SPG on Patients of Cervical Cancer with Irradiation Therapy / I.Kohno et al. / p374~374
  • General Lecture 174.Basic Study on Brain Tumor Therapy Using Mumpus Virus / N.Oka et al. / p374~374
  • General Lecture 175.Not Received / /
  • General Lecture 176.Prolongation of Survival Periods and Reevaluation of Immunological Parameters in Cancer Patients of the Gastrointestinal Tract Treated with Nonspecific Immunotherapy / H.Hanaue et al. / p375~375
  • General Lecture 177.Effect of Chemo-and Immunochemo-therapy on Highly Advanced Gastric(Stage IV)and Colorectal(Stages IV&V)Cancer / Y.Tabuchi et al. / p375~375
  • General Lecture 178.In vitro Sensitivity Test of Human Tumor Stem Cells to Anticancer Drugs / M.Usugane et al. / p375~375
  • General Lecture 179.A Clinical Study of the Clonogenic Assay / T.Kubota et al. / p376~376
  • General Lecture 180.An Evaluation of Anticancer Drugs against Xenotransplantable Human Prostatic Cancer(PC-3)by Clonogenic Assay / K.Ohmura et al. / p376~376
  • General Lecture 181.In vitro Chemosensitivity Study of Urologic Malignancies by Clonogenic Assay / T.Hashimura et al. / p376~376
  • General Lecture 182.Chemosensitivity Test of Urologic Malignancies with in vitro Stem Cell Assay / T.Sakuramoto et al. / p377~377
  • General Lecture 183.Correlationship between Human Tumor Stem Cell Assay in vitro and Clinical Effects in vivo / N.Yamamoto et al. / p377~377
  • General Lecture 184.Basic Study on a New Sensitivity Test against Anticancer Agents for Brain Tumor Cells Using Flow Cytometry(FCM) / K.Kawakami et al. / p377~377
  • General Lecture 185.The Drug Sensitivity in vitro of Human Small Cell Carcinoma Cells and It's Clinical Application / S.Kobayashi et al. / p378~378
  • General Lecture 186.Sensitivity Assay of Anti-cancer Agents with Suppression of ³H-TdR Uptake of Cancer Cells in Breast Cancer / T.Inamoto et al. / p378~378
  • General Lecture 187.In vitro and in vivo Chemosensitivity Tests of Human Colon Carcinoma Strains / M.Watanabe et al. / p378~378
  • General Lecture 188.A Study of Comparative Chemosensitivity in Exponential-versus Plateau-Phase Cultures of KN-41 Renal Cancer Cells / A.Nishino et al. / p379~379
  • General Lecture 189.Sensitivity of Anti-cancer Agents against Human Gastrointestinal Cancer Transplanted into Nude Mice / M.Yamauchi et al. / p379~379
  • General Lecture 190.Evaluation of Chemotherapy for Human Pancreatic Carcinoma Xenografts / H.Hisano et al. / p379~379
  • General Lecture 191.Cell Kinetics and Chemosensitivity of the Human Carcinomas Serially Transplanted into Nude Mice / T.Inada et al. / p380~380
  • General Lecture 192.Correlation between in vitro Chemosensitivity of Human Tumors and the Corresponding Xenografts in Nude Mice / Y.Mizuno et al. / p380~380
  • General Lecture 193.Clinical Management of Prostatic Cancer--Results of Chemotherapy / K.Kubota et al. / p380~380
  • General Lecture 194.Enhancement of Methotrexate Cytotoxicity under the Insulin Addition in Human Choriocarcinoma Cells in vitro / T.Hirama et al. / p381~381
  • General Lecture 195.Basic and Clinical Study on Treatment for Refractory Choriocarcinoma / O.Kobayashi et al. / p381~381
  • General Lecture 196.Effects of Bleomycin-Mitomycin Therapy for Lung Metastasis of Uterine Cervical Cancer / M.Mimura et al. / p381~381
  • General Lecture 197.Clinical Analysis of Cervical Adenocarcinoma / M.Inagaki et al. / p382~382
  • General Lecture 198.Clinical Study of Cervical Cancer in Oita Prefectural Hospital (1965~1982) / I.Taniguchi et al. / p382~382
  • General Lecture 199.Prognostic Significance of Depth of Tumor Invasion / T.Inoue et al. / p382~382
  • General Lecture 200.Study of Relapse in the Patients with Trophoblastic Tumors / K.Hirokawa et al. / p383~383
  • General Lecture 201.Study on the Metastasis of a Choriocarcinoma to the Brain / T.Fuchi et al. / p383~383
  • General Lecture 202.Late Recurrences of Ovarian Epithelial Carcinoma / Y.Matsumoto et al. / p383~383
  • General Lecture 203.Combination Chemotherapy of Advanced Ovarian Cancer / H.Iwasawa et al. / p384~384
  • General Lecture 204.VAB III Treatment of Advanced Endodermal Sinus Tumors with Liver Metastases / N.Tsukamoto et al. / p384~384
  • General Lecture 205.Adjuvant Therapy for Ovarian Cancer with Marked Ascites (Effect of Intraperitoneal In-jection of OK 432 and t-AMCHA) / I.Kizawa et al. / p384~384
  • General Lecture 206.UFT-M Chemotherapy for Ovarian Cancer(No.2) / Y.Uchida et al. / p385~385
  • General Lecture 207.Comparative Study of m-Gastric Carcinoma and sm-Gastric Carcinoma / S.Kanabe et al. / p385~385
  • General Lecture 208.Results of Surgical Treatment of Similar Early Gastric Cancer in 82 Patients / K.Azekura et al. / p385~385
  • General Lecture 209.Comparison of 2 Types of Gastric Cancer / K.Matsumura et al. / p386~386
  • General Lecture 210.Pathological Feature and X ray Diagnosis of the Gastric Cancer with Esophageal Invasion / T.Ogino et al. / p386~386
  • General Lecture 211.Not Received / /
  • General Lecture 212.Studies of Lymphatic Flow of Gastric Carcinoma to Para Aortic Nodes / M.Yoshida et al. / p386~386
  • General Lecture 213.Study on Perigastric Lymphatic Circulation by Preoperative Endoscopic Injection of India Ink in Gastric Wall Around Cancer Lesion / H.Isozaki et al. / p387~387
  • General Lecture 214.Liver Metastasis of Gastric Cancer / K.Yoshikawa et al. / p387~387
  • General Lecture 215.Diagnosis of Liver Metastasis in Patients with Gastric Cancer:Reliability in Various Laboratory and Radiological Tests Including 5-NPD V(5-Nucleotide Phosphodiesterase Isoenzyme V)Assay and Intraoperative Ultrasonography / H.Kenmizaki et al. / p387~387
  • General Lecture 216.A Clinicopathological Study of Postoperative Bone Metastasis in Resected Gastric Cancer / O.Izuno et al. / p388~388
  • General Lecture 217.The Clinicopathological Study of the Lymphnode Metastasis of the Head of the Pancreas / R.Ohyama et al. / p388~388
  • General Lecture 218.Clinicopathological Studies on Percutaneous Transhepatic Biopsy of Biliary Tract / S.Toyoda et al. / p388~388
  • General Lecture 219.Histopathological Investigation on Oral Precancerous Lesions, IV / K.Tsuchikawa et al. / p389~389
  • General Lecture 220.Studies on the Host-tumor Relationship in Oral Cancer 1.Clinical Diagnosis and Primary Lesions / T.Tagami et al. / p389~389
  • General Lecture 221.Parapharyngeal Space Invasion of Head and Neck Cancer / M.Okuda et al. / p389~389
  • General Lecture 222.The Relation between the Cervical Lymphnodes Metastasis and the Prognosis of Cancer of the Head and Neck / M.Asai et al. / p390~390
  • General Lecture 223.A Retrospective Review of Distant Metastases of Nasopharyngeal Carcinoma / K.Iida et al. / p390~390
  • General Lecture 224.Incidents of Metastases in Relatively Small Carcinomas of the Tongue with Vascular Involvement / T.Matsushima et al. / p390~390
  • General Lecture 225.Clinicopathological Study on Renal Cell Carcinoma / S.Naito et al. / p391~391
  • General Lecture 226.Pathological Investigation of Renal Cell Carcinoma / S.Nakanishi et al. / p391~391
  • General Lecture 227.Clinico-Pathological Research of Renal Cell Carcinoma 3.Histopathological View and Clinical Characteristics of Grade 2 & 3 / Y.Senga et al. / p391~391
  • General Lecture 228.Clinicopathological Study of Prostatic Carcinoma VI: Application of Gleason's Grading to the Cases in Japan with Reference to VACURG Studies / K.Uchida et al. / p392~392
  • General Lecture 229.Flow Cytometric Analysis in the Diagnosis and Classification of Urogenital Malignancies / T.Yamauchi et al. / p392~392
  • General Lecture 230.Surface Phenotype,Clinical Characteristics and Chemotherapy Effects of Acute Lymphocytic Leukemia in Adult / T.Koh et al. / p392~392
  • General Lecture 231.Metastatic Patterns and an Indication of Treatment for Metastatic Lesions of Germ Cell Tumors of Testis / H.Saitoh et al. / p393~393
  • General Lecture 232.Clinical and Pathological Study on Various Metastases Secondary to Nephrected Renal Cell Carcinoma / T.Ohnishi et al. / p393~393
  • General Lecture 233.Brain Metastasis from Renal Cell Carcinoma / F.Masuda et al. / p393~393
  • General Lecture 234.Silent Brain Metastasis / J.Uki et al. / p394~394
  • General Lecture 235.The Study on Metastasis of Carcinoma of Uterine Cervix to Skin / A.Kurokawa et al. / p394~394
  • General Lecture 236.The Vaginal Spread of Cervical Carcinoma / N.Chen et al. / p394~394
  • General Lecture 237.Histogenic Difference between the Metaplastic Change and the Bulky Outgrowth in C.I.S. / T.Muroya et al. / p395~395
  • General Lecture 238.Clinicopathological Findings and Spread of Uterine Cervical Cancer / K.Shibata et al. / p395~395
  • General Lecture 239.A Study on Subclassification of Squamous Cell Carcinoma of the Uterine Cervix / Y.Sakai et al. / p395~395
  • General Lecture 240.Clinical Significance of Nuclear DNA Pattern in Uterine Cervical Adenocarcinoma / Y.Hayashi et al. / p396~396
  • General Lecture 241.Effect of 1-Hexylcarbamoyl-5-Fluorouracil(HCFU)and 1-(2-Tetrahydrofuryl)-5-Fluorouracil(Tegafur)on Transplantable Human Gastric Cancers in BALB/c Nude Mice / R.Akimoto et al. / p396~396
  • General Lecture 242.Antitumor Effect of α-Difluoromethylornithine(DFMO)against a Human Tumor Xenograft(MX-1)Serially Transplanted into Nude Mice / F.Asanuma et al. / p396~396
  • General Lecture 243.Chemotherapy of Human Pseudo Myxoma Transplanted in the Nude Mice / K.Miyahara et al. / p397~397
  • General Lecture 244.Effect of Monoclonal Antibody-mitomycin C Conjugate on Growth of Human Colon Carcinoma Transplanted to Nude Mice / N.Ogata et al. / p397~397
  • General Lecture 245.Effects of K-18 against Transplantable Human Cancer in Nude Mouse / K.Nakatani et al. / p397~397
  • General Lecture 246.Combination Chemotherapy with FT-207 and Amphotericine B in Advanced Gastric Cancer / S.Akazawa et al. / p398~398
  • General Lecture 247.The Effect of Lipopolysaccharide Immobilized Fiber on the Vx2 Tumor of the Rabbits / T.Tani et al. / p398~398
  • General Lecture 248.Experimental Studies on Cyclophosphamide Pretreatment in Tumor Cryotherapy / K.Miya et al. / p398~398
  • General Lecture 249.Clinical Studies on the Life History of Colo-rectal Adenoma and Cancer / M.Tada et al. / p399~399
  • General Lecture 250.Effect of Kallidinogenase on the Proliferation and Metastasis of Carcinoma Cells and Platelet Aggregation / Y.Kawai et al. / p399~399
  • General Lecture 251.Homostatic Disorder in Hemopoietic Malignancy / M.Tsuda et al. / p399~399
  • General Lecture 252.Microangiopathic Hemolytic Anemia with Disseminated Intravascular Coagulation in Metastatic Carcinoma / R.Takeuchi et al. / p400~400
  • General Lecture 253.The Combination Therapy for the Experimental Tumor with Hyperbaric Oxygenation(abb.OHP)and Anti-tumor Antibiotics / H.Sugiyama et al. / p400~400
  • General Lecture 254.Effects of Hyperbaric Oxygenation and ACNU in Experimental Bladder Tumor / T.Akiya et al. / p400~400
  • General Lecture 255.ACNU Delivery to Malignant Brain Tumor Tissue and Serum--Route of Administration and Effect of Phenobarbital / K.Muraoka et al. / p401~401
  • General Lecture 256.Experimental Study on Proliferation Kinetics of Residual Tumor Cells Following Operation for Malignant Tumor / Y.Saitoh et al. / p401~401
  • General Lecture 257.Cell Kinetics and Clinical Features of Acute Lymphoblastic Leukemia(ALL)in Children / Y.Kato et al. / p401~401
  • General Lecture 258.Clinicostatistical Observation on Renal Cell Carcinoma / O.Yoshizumi et al. / p402~402
  • General Lecture 259.Ten Years Operative Results of Renal Carcinoma With Special Reference to Radical Nephrectomy / S.Kumagai et al. / p402~402
  • General Lecture 260.Survival of Patients with Transitional Cell Carcinoma Treated by Surgery:Comparative Results of the Old,Mid and Recent Series / T.Saiki et al. / p402~402
  • General Lecture 261.Bladder Cancer in Aged Patients / S.Isaka et al. / p403~403
  • General Lecture 262.Partial Nephrectomy for Renal Carcinoma:Report of 4 Cases / Y.Tachibana et al. / p403~403
  • General Lecture 263.The Treatment of the Superficial Bladder Tumor with Intravesical Chemotherapy after Transurethral Resection / K.Kudoh et al. / p403~403
  • General Lecture 264.The Value of Urethrectomy in Patients of Urinary Bladder Cancer / M.Sugimoto et al. / p404~404
  • General Lecture 265.Clinico-pathological Studies of Total Cystectomy for Bladder Cancer / J.Satoh et al. / p404~404
  • General Lecture 266.Treatment of Renal Cell Carcinoma by Neocarzinostatin(NCS) / K.Tari et al. / p404~404
  • General Lecture 267.Chemotherapy of Renal Cell Carcinoma 3. Single-agent Therapy with FT-207 or Vinblastine / Y.Satomi et al. / p405~405
  • General Lecture 268.Efficacy of Vinca Alkaloids,Carbazilquinone and Cyclophosphamide Combination Chemotherapy in Patients with a Variety of Malignant Neoplasms / C.Konda et al. / p405~405
  • General Lecture 269.CPA-ADR-ACNU Combination Chemotherapy with Autologous Bone Marrow Transplantation in Advanced Solid Tumors / T.Tajima et al. / p405~405
  • General Lecture 270.P-VEMPFA Therapy for Head and Neck Malignant Tumor / H.Saito et al. / p406~406
  • General Lecture 271.Sequential MTX and 5-FU in the Head and Neck Cancer / M.Horiuchi et al. / p406~406
  • General Lecture 272.Chemotherapy of Pulmonary Metastasis of Head and Neck Cancer / J.Tanaka et al. / p406~406
  • General Lecture 273.Study on Preoperative Irradiation in the Treatment of Cancer of the Uterine Cervix / M.Hayafuji et al. / p407~407
  • General Lecture 274.Intraoperative Radiotherapy for Uterine Cervical Cancer / M.Imachi et al. / p407~407
  • General Lecture 275.Relationship between Prognosis and Lymphnode Metastases in Patients with Postoperative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Tanaka et al. / p407~407
  • General Lecture 276.Postoperative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Honke et al. / p408~408
  • General Lecture 277.The Significance of Tumor Response as a Prognostic Factor during Radiotherapy in Uterine Cervix Cancer / Y.Kikuchi et al. / p408~408
  • General Lecture 278.Radiotherapy for Carcinoma of the Uterine Cervix / Y.Takegawa et al. / p408~408
  • General Lecture 279.Analysis of Atypical Treatment Method of Intracavitary Irradiation for Carcinoma of the Uterine Cervix / S.Satoh et al. / p409~409
  • General Lecture 280.Relationship between Histological Classification and Local Control Rate in the Cases of Carcinoma of the Uterine Cervix, Treated by Fast Neutrons and Photons / S.Morita et al. / p409~409
  • General Lecture 281.Pre or Post-operative Radiotherapy for Carcinoma of the Uterine Cervix / Y.Kawamura et al. / p409~409
  • General Lecture 282.Three to Four Year Survival Rate of the Carcinoma of the Cervix Uteri Treated with Immuno-,Chemo-,and Radiation Therapy / M.Saito / p410~410
  • General Lecture 283.Five Years Follow up Uterine Cervical Carcinomas Treated with Ralstron and Para-aorta Lymphnode Irradiation / A.Murakami et al. / p410~410
  • General Lecture 284.Basic and Clinical Study on the Irradiation and Hyperthermia Therapy of Uterine Carcinoma / M.Tsuchida et al. / p410~410
  • General Lecture 285.Clinical Evaluation of Serum CEA Levels and Immunoperoxidase Staining for CEA in Uterine Cervix Cancer / K.Takahashi et al. / p411~411
  • General Lecture 286.Radiotherapy Combined with Intermittent Administration of Misonidazole and ACNU / H.Asakura et al. / p411~411
  • General Lecture 287.Palliative Radiotherapy in the Management of Bone and Brain Metastatic Disease / T.Watari et al. / p411~411
  • General Lecture 288.Not Received / /
  • General Lecture 289,Radiotherapy for Malignant Solid Tumor in Childhood--Intraoperative Irradiation / N.Ohnuma et al. / p412~412
  • General Lecture 290.Afterloading Interstitial Brachytherapy by Ir-192 Seed Assembly for the Malignant Brain Tumor / M.Nishio et al. / p412~412
  • General Lecture 291.Evaluation of Preoperative Irradiation for Malignant Brain Tumors / T.Shiina et al. / p412~412
  • General Lecture 292.ACNU-induced G₂M Accumulation and Its Significance to the Modification of the in vitro Radiation Response / N.Murakami et al. / p413~413
  • General Lecture 293.Radiotherapy for Cancer of the Maxillary Sinus, with Boost Therapy by Low Dose Rate Intracavitary Irradiation / M.Takayama et al. / p413~413
  • General Lecture 294.Radiation Therapy of Primary Nasal and Paranasal Sinus Carcinoma / H.Miyashita et al. / p413~413
  • General Lecture 295.Fast-Neutron Radiotherapy for Recurrent Osteogenic Sarcoma of the Maxilla / K.Hayasaki et al. / p414~414
  • General Lecture 296.Maxillary Sinus Carcinoma / H.Shibuya et al. / p414~414
  • General Lecture 297.Recurrence Factors of the Maxillary Cancer after Multimodal Treatment from the View Point of Radiotherapy / N.Fuwa et al. / p414~414
  • General Lecture 298.Analysis of Causes of Dead Patients with Treated Tongue Cancer(T₁ and T₂) / E.Takenaka et al. / p415~415
  • General Lecture 299.Result of Treatment for T1NO Glottic Carcinoma / Y.Akine et al. / p415~415
  • General Lecture 300.Radiotherapy of Laryngeal Cancer / A.Ajimu et al. / p415~415
  • General Lecture 301.Radiation Therapy of the Early Glottic Cancer / K.Hayakawa et al. / p416~416
  • General Lecture 302.Revaluation of Radiation Therapy for T1NOMO Glottic Carcinoma
  • Investigation of the Immobilization Method Using Semi-conductor Dosimeter / M.Chatani et al. / p416~416
  • General Lecture 303.Oncologic Emergency Irradiation / Y.Nakashima et al. / p416~416
  • General Lecture 304.Radioiodine I-131 Therapy in the Treatment of Pulmonary Metastases from Thyroid Carcinoma / K.Kusakabe et al. / p417~417
  • General Lecture 305.Multiple Primary Malignant Neoplasms / T.Okawa et al. / p417~417
  • General Lecture 306.Clinical Study on Multiple Primary Malignant Neoplasms / S.Yui et al. / p417~417
  • General Lecture 307.Increasing of Primary Multiple Cancer in the Head and Neck Region / Y.Matsumura et al. / p418~418
  • General Lecture 308.Multiple Primary Malignancies in Head and Neck Cancer / S.Ebihara et al. / p418~418
  • General Lecture 309.Study on the Double Cancer / K.Yao et al. / p418~418
  • General Lecture 310.Clinical Studies on Multiple Primary Cancer and Postirradiation Sarcoma / S.Higashi et al. / p419~419
  • General Lecture 311.Secondary and Multiple Cancers after Radiotherapy for Cancer of the Oral Region / J.Horiuchi et al. / p419~419
  • General Lecture 312.Double Cancer of Esophagus and Other Organ--A Study of 60 Cases / H.Amano et al. / p419~419
  • General Lecture 313.Analysis of Patients with Multiple Primary Cancers in the Sphere of Gastroenterological Surgery--Especially Sequential Cancer Lesion after Treatment for Primary Lesion / H.Nishidoi et al. / p420~420
  • General Lecture 314.Study on 116 Cases of Gastric Cancer Complicated by Cancer of Other Organs / H.Suzuki et al. / p420~420
  • General Lecture 315.Statistical Studies on the Cases with Gastric Cancer Combined with Cancer in Other Organs:445 Cases out of 66 Hospitals in Japan / K.Yoshino et al. / p420~420
  • General Lecture 316.Clinical Report of an Over 21 Years Successfully Treated and Survived Case with Oral Multiple Cancers and Early Gastric Cancer / K.Todaka et al. / p421~421
  • General Lecture 317.A Clinical Study on Multiple Cancers of Colon and Rectum / T.Shimizu et al. / p421~421
  • General Lecture 318.Detection of Second Primary Cancer in a Screening Program of Stage I Lung Cancer Patients after Resection / K.Iuchi et al. / p421~421
  • General Lecture 319.Four Cases Reports of Sarcoma Combined with Carcinoma / Y.Ubayama et al. / p422~422
  • General Lecture 320.Thirty-four Cases of Hematological Malignancies Associated with Solid Tumors / N.Horikoshi et al. / p422~422
  • General Lecture 321.Second Malignancies in Non-Hodgkin's Lymphoma / K.Sakai et al. / p422~422
  • General Lecture 322.Two Patients with Triple Cancers in the Breast Cancer / H.Abe et al. / p423~423
  • General Lecture 323.Multiple Primary Carcinomas of the Uterus and Radiation-induced Carcinomas / J.Ishii et al. / p423~423
  • General Lecture 324.Late Development of Sarcoma in the Radiation Field Following Treatment of Cervical Cancer / R.Tsunematsu et al. / p423~423
  • General Lecture 325.Double Primary Carcinoma of the Vulva and Cervix / I.Tsukiyama et al. / p424~424
  • General Lecture 326.Effect of Mitoxantrone against Primary and Recurrent Breast Cancer / T.Tsukui et al. / p424~424
  • General Lecture 327.Chemotherapy against Hepatocellular Carcinoma(HC)in vitro.(Second Report)--Comparison of Anticancer Effect between Daunomycin(DAM)and Conjugated DAM with Antibodies to Human α-Fetoprotein(CONJ) / K.Kukita et al. / p424~424
  • General Lecture 328.Treatment of Hepatoma with Conjugate of Adriamycin and Anti-a-fetoprotein Anti-body / Y.Une et al. / p425~425
  • General Lecture 329.A Combined Effect of Adriamycin and Hyperthermia on Cellular Uptake of ³H-Thymidine in Ehrlich Ascites Tumor Cells in vitro / K.Naito et al. / p425~425
  • General Lecture 330.An Aspect of the Intravenous Drop Infusion of Adriacin(Part 2) / H.Masuda et al. / p425~425
  • General Lecture 331.Phase II & Preliminary Phase III Clinical Trials of 4'-O-tetrahydropyranyladriamycin(THP-ADM)for Hematopoietic Malignancies / Y.Fujiwara et al. / p426~426
  • General Lecture 332.Clinical and Experimental Studies on THP-adriamycin for Breast Cancer / K.Fujiwara et al. / p426~426
  • General Lecture 333.Clinical Study of 4'-O-Tetrahydropyranyl Adriamycin (THP) / H.Majima et al. / p426~426
  • General Lecture 334.Intravesical Therapy with 4'-epi-Adriamycin in Patients with Superficial Bladder Tumors / T.Tsushima et al. / p427~427
  • General Lecture 335.Effects of Aclacinomycin A on Urogenital Malignancies / S.Noguchi et al. / p427~427
  • General Lecture 336.Chemotherapy of Malignant Ovarian Tumors / N.Ohhama et al. / p427~427
  • General Lecture 337.Non-invasive Cardiac Evaluation of Patients Receiving Anthracycline / I.Maekawa et al. / p428~428
  • General Lecture 338.Protective Effect of Coenzyme Q in Cardiotoxicity of Adriamycin / K.Okuma et al. / p428~428
  • General Lecture 339.Protective Effect of Coenzyme Q₁₀ on Chronic Adriamycin Cardiomyopathy / Y.Uekita et al. / p428~428
  • General Lecture 340.Prevention of Adriamycin-related Alopecia with Scalp Cooling / Y.Kidera et al. / p429~429
  • General Lecture 341.Clinical Response with Cis-diammine-dichloro Platinum in Esophageal Cancer / T.Sasaki et al. / p429~429
  • General Lecture 342.A Combination Chemotherapy of Cis-Dichlorodiammineplatinum(II)(CDDP)and Bleomycin(BLM)in Advanced Esophageal Carcinoma / M.Hayakawa et al. / p429~429
  • General Lecture 343.Combination Chemotherapy of CDDP in Esophageal Cancer Patients / T.Yoshihara et al. / p430~430
  • General Lecture 344.Cis-Dichlorodiaminneplatinum(II)in Treatment of Esophageal Carcinoma / Y.Murata et al. / p430~430
  • General Lecture 345.Intraarterial Infusion Therapy with CDDP for Liver Tumor / M.Miyagiwa et al. / p430~430
  • General Lecture 346.Clinical and Pathological Studies of a Case of Recurrent Fallopian Tubal Carcinoma with Cisplatin Therapy / K.Fujinawa et al. / p431~431
  • General Lecture 347.Not Received / /
  • General Lecture 348.CDDP-ACR Combination Chemotherapy for Malignant Ovarian Tumors / T.Jobo et al. / p431~431
  • General Lecture 349.Combination Chemotherapy of Primary Ovarian Cancer with Cis-platinum,Aclacli-nomycin A and FT-207 / T.Tase et al. / p431~431
  • General Lecture 350.Cisplatin and PAC (Cisplatin,Adriamycin,Cyclophosphamide)Chemotherapy for Advanced Ovarian Carcinomas / M.Yamasaki et al. / p432~432
  • General Lecture 351.Chemotherapy of Gynecological Malignancies with Cisplatin Combination Therapy / K.Takakuwa et al. / p432~432
  • General Lecture 352.Studies on Preoperative Chemotherapy for Advanced Ovarian Cancer with Cisplatin / S.Izumi et al. / p432~432
  • General Lecture 353.Intrapleural and Intraperitoneal Administration of Cis-platinum Combined with In-travenous Injection of Sodium Thiosulphate--Two Channel Chemotherapy-for 4 Ovarian Carcinomas and 3 Other Gynecological Malignancies / M.Hatae / p433~433
  • General Lecture 354.The Effects of Cisplatin on Malignant Ovarian Tumors were Studied Prospectively / Y.Nishida et al. / p433~433
  • General Lecture 355.Chemotherapy of Advanced Epitherial Ovarian Cancer with Combination of Cisplatin(P),Adriamycin(A),and Cyclophosphamide(C) / R.Tsunematsu et al. / p433~433
  • General Lecture 356.The Role of Cisplatin in the Treatment of Advanced Gynecological Malignancies / K.Hirabayashi et al. / p434~434
  • General Lecture 357.Cis-platinum,Vinblastine,Bleomycin-Chemotherapy for Uterine Cervical Carcinomas / K.Ueda et al. / p434~434
  • General Lecture 358.Cis-Platinum,Adriamycin and Cyclophosphamide Therapy for Brain Metastasis of Tubal Carcinoma / M.Ikeuchi et al. / p434~434
  • General Lecture 359.Antitumor Activity of Cisplatin against Malignant Brain Tumors / K.Kato et al. / p435~435
  • General Lecture 360.A Combination Chemotherapy with Cis-Platinum,Vincristine,and Peplomycin for Squamous Cell Carcinoma / Y.Araki et al. / p435~435
  • General Lecture 361.The Effect of Cisplatin to the Head and Neck Cancer / T.Sonoda et al. / p435~435
  • General Lecture 362.Protective Effect of Fosfomycin from Cis-platinum-induced Nephrotoxicity in Head and Neck Cancer Patients / K.Tanaka et al. / p436~436
  • General Lecture 363.Clinical Study of Combination Chemotherapies for Recurrent Head and Neck Cancer with Cis-Diamminedichloroplatinum(CDDP),BLM and MTX(Regimen 1),as well as with CDDP and Pepleomycin(Regimen 2) / A.Noguchi et al. / p436~436
  • General Lecture 364.CAP Therapy in Hormone Refractory Prostatic Cancer / M.Sasaki et al. / p436~436
  • General Lecture 365.Favorable Effect of Preoperative Multi-drug Chemotherapy and Radiation Therapy in Children with Disseminated Embryonal Cell Carcinoma / S.Ishizone et al. / p437~437
  • General Lecture 366.High Dose Cisplatinum Therapy of Malignant Neurogenic Tumors in Children / A.Nakagawara et al. / p437~437
  • General Lecture 367.Therapy of Neuroblastoma with Combination Chemotherapy Including Cis-platin / F.Bessho et al. / p437~437
  • General Lecture 368.A Clinical Study of Cis-DDP Induced Nephrotoxicity in the Patients with Advanced Urogenital Malignancies / K.Suzuki et al. / p438~438
  • General Lecture 369.Antiemetic Effect of Beta-methazone with Droperidol--Compared with High Dose of Beta-methazone and Half Dose of Beta-methazone with Droperidol in Chemotherapy-induced Emesis and Neusea / K.Min et al. / p438~438
  • General Lecture 370.Influence of Methylprednisolone on Antitumor Effect of CDDP / K.Lee et al. / p438~438
  • General Lecture 371.Management of the Cancer Drug Emesis--How to Control the Emesis Associated with Platinum / M.Nakanami et al. / p439~439
  • General Lecture 372.Review of Intra-Arterial Infusion-Radiation Therapy for Lingual Cancer / Y.Nomura et al. / p439~439
  • General Lecture 373.Intraarterial Chemotherapy for the Head and Neck Cancer / N.Kohno et al. / p439~439
  • General Lecture 374.Clinical and Histological Evaluation of Effects of Intra-Arterial Infusion Chemotherapy for the Patients with Primary Advanced Breast Cancer / K.Toda et al. / p440~440
  • General Lecture 375.Effect of Intra-arterial Infusion of Adriamycin on Locally Advanced Primary Breast Cancer(No.2) / K.Sakai et al. / p440~440
  • General Lecture 376.Balloon Occuluded Hepatic Infusion of Vindesine (BOHI of VDS)for Liver Metastasis in Refractory Breast Cancer / T.Tabei et al. / p440~440
  • General Lecture 377.Intraarterial Infusion Chemotherapy for Locally Advanced and Recurrent Breast Cancer / H.Iwasaki et al. / p441~441
  • General Lecture 378.The Evaluation of Preoperative One Shot Bronchial Artery Infusion to the Primary Bronchogenic Carcinoma--Analysing the Influence to the Survival / Y.Lee et al. / p441~441
  • General Lecture 379.Results of Several Modifications of Continuous Intra-arterial Infusion Therapy for Metastatic Tumor of Liver from Gastrointestinal Cancers / K.Okuyama et al. / p441~441
  • General Lecture 380.Combination Chemotherapy against Inoperable Liver Cancer (3rd Report) -study on the MQ-F-OK Therapy Including Intraarterial Administration of MMC and CQ,and the Background Factors / K.Tsushima et al. / p442~442
  • General Lecture 381.Therapy of Metastatic Liver Tumors / A.Narihiro et al. / p442~442
  • General Lecture 382.A Histologic Study of the Forepart of Infiltrating Cervical Cancer Subjected to Preoperative Continuous Arterial Infusion Chemotherapy / A.Utsunomiya et al. / p442~442
  • General Lecture 383.Clinical Effectiveness of Surgical Chemotherapy on Advanced Uterinecervical Cancer / M.Iwasaki et al. / p443~443
  • General Lecture 384.Limitation of Long-term Intra-arterial Infusion Chemotherapy for Bladder Cancer / S.Kanoh et al. / p443~443
  • General Lecture 385.Significance of CDDP One-shot Intraarterial Infusion Therapy in Bladder Cancer / Y.Kubota et al. / p443~443
  • General Lecture 386.Intra-arterial Infusion for Pelvic Cancers / M.Kita et al. / p444~444
  • General Lecture 387.Intra-Arterial Infusion Chemotherapy in the Treatment for Soft Tissue Sarcomas of the Limbs / Y.Beppu et al. / p444~444
  • General Lecture 388.Long Term Follow-up Result of Pre-operative Intra-arterial Infusion Treatment for Malignant Bone and Soft Tissue Tumor of Extremities / M.Tsuneda et al. / p444~444
  • General Lecture 389.Local Therapy of the Breast Cancer by Adriamycin Ointment / S.Shimizu et al. / p445~445
  • General Lecture 390.Successful Treatment of Skin Cancer and Leukoplakia Using 5-FU Salve(5-FUS)and 5-FU Paste(5-FUP)Manufactured for Trial / S.Ishibashi et al. / p445~445
  • General Lecture 391.Slow Released Anticancer Agent Prepared by Combination of 5-Fluorouracil and Poly-glycolic Acid / M.Hirano et al. / p445~445
  • General Lecture 392.The Effect of Angiotensin II on the Tissue Distribution of Liposomes: Experimental Study / H.Shimizu et al. / p446~446
  • General Lecture 393.Studies on the Mechanism of Cytotoxic Effect of 5-Fluorouracil Different Effect for the Concentration of 5-Fu in vitro / K.Naito et al. / p446~446
  • General Lecture 394.Comparative Study of the Metabolism of Fluorinated Pyrimidines,5-FUR and 5-FUdR,in Human Tissues / M.Uchida et al. / p446~446
  • General Lecture 395.A Study on the Concentration of 5FU Derivatives(THFU)in the Plasma and the Cancer Tissue after Its Oral Administration / T.Ohno et al. / p447~447
  • General Lecture 396.Preoperative Chemotherapy for Gastric Cancer by Dripping Intravenous Infusion of FT-207 I. Analysis of 5-FU Concentrations in Sera and Tissues / H.Kikuchi et al. / p447~447
  • General Lecture 397.Investigation of Serum Assay of 5-FU through 5-FU and FT-207 Intravenous Con-tinuous Infusion / T.Kato et al. / p447~447
  • General Lecture 398.A Study on Preoperative Chemotherapy with Tegafur in Cervical Cancer / T.Kanda et al. / p448~448
  • General Lecture 399.Prophylactic Long-term Treatment of Bladder Tumors with Oral Chemotherapy by Tegafur / I.Higa et al. / p448~448
  • General Lecture 400.Clinical Experience with SF-SP A New Type Capsule Preparation of Tegafur / K.Ri et al. / p448~448
  • General Lecture 401.Comparative Study on Two Different Internal Drugs of Tegafur for Recurrent Breast Cancer / T.Taguchi et al. / p449~449
  • General Lecture 402.Phase II Study on SF-SP (Orally Administrated Spansule Tegafur) / T.Taguchi et al. / p449~449
  • General Lecture 403.Histological Evaluation on the Effect of Preoperative Intrarectal Administration of 5-FU Emulsion for Rectal Cancer / H.Takatori et al. / p449~449
  • General Lecture 404.Studies on Prophylactic Treatment with 5 FU Dry Syrup and Ftoraful Suppository for the Relapse of Bladder Cancer / I.Kondo et al. / p450~450
  • General Lecture 405.Pre-& Post-operative Administration of FT-207 Suppositories for Adjuvant Chemotherapy of Colorectal Cancer / K.Ueno et al. / p450~450
  • General Lecture 406.Experimental and Clinical Evaluation of Tegafur Suppository and Glutation for Walker 256 Carcinoma and Gastrocolonic Cancer as Preoperative Adjuvant Chemotherapy / M.Kitajima et al. / p450~450
  • General Lecture 407.Clinical Application of Tegafur Suppositories for Bladder Tumor / T.Mishina et al. / p451~451
  • General Lecture 408.Fundamental and Clinical Studies on Tissue Distribution of UFT / S.Arima et al. / p451~451
  • General Lecture 409.Study on the Concentration of Serum and Tumor in Advanced Stomach Cancer after the Oral Administration of UFT / T.Takeshita et al. / p451~451
  • General Lecture 410.Comparison between Blood and Lymphatic Transport of UFT and Tegafur / H.Hanaue et al. / p452~452
  • General Lecture 411.In situ Activation Mechanisms of Anticancer Agents(Masked Compounds)and Cancer Chemotherapy / Y.Yoshida et al. / p452~452
  • General Lecture 412.Methods in Evaluating Histologic Effects of Oral Administration of Tegafur and UFT in Gastric Cancers / J.Fujimoto / p452~452
  • General Lecture 413.Concentration of 1-Hexylcarbamoyl-5-fluorouracil(HCFU)and 5-Fluorouracil(FU)in Various Tissues from Rats and from Patients with Colon Cancers / T.Kosaka et al. / p453~453
  • General Lecture 414.Clinical Evaluation of 1-hexylcarbamoyl-5-fluorouracil(HCFU)in Hepatocellular Carcinoma / K.Shiraishi et al. / p453~453
  • General Lecture 415.A Clinical Trial of Carmoful(HCFU)in the Treatment of Ovarian Carcinoma / T.Noda et al. / p453~453
  • General Lecture 416.Study on the Side Effects of Postoperatively Administered HCFU(MIFROL) / H.Izumi et al. / p454~454
  • General Lecture 417.Clinical Study of 5'-DFUR / K.Hasegawa et al. / p454~454
  • General Lecture 418.Effects of 5'-DFUR on Patients with Gastric,Colorectal and Breast Cancer / T.Tominaga et al. / p454~454
  • General Lecture 419.Studies on Hormone Dependency of Thyroid Carcinomas / M.Miyakawa et al. / p455~455
  • General Lecture 420.Estrogen Receptors in Gastrointestinal Cancers / Y.Sato et al. / p455~455
  • General Lecture 421.Estrogen and Progesterone Receptor of the Stomach Cancer / M.Hori et al. / p455~455
  • General Lecture 422.Hormone Receptors in Human Breast Cancer / H.Sonoo et al. / p456~456
  • General Lecture 423.Relationship between Hormone Receptors in Human Breast Cancer and Nuclear Grade / T.Nishi et al. / p456~456
  • General Lecture 424.Hormonal Profiles and Structures in Normal Women and in Patients with Benign and Malignant Breast Diseases / E.Imayoshi et al. / p456~456
  • General Lecture 425.Patients with Prostatic Cancer and Thrombosis during Estrogen Therapy (On Significance of Measurement of Antithrombin III Activity) / T.Tochigi et al. / p457~457
  • General Lecture 426.Histological Study on the Relationship between Hyperplasia and Corpus Carcinoma / H.Sakahira et al. / p457~457
  • General Lecture 427.Gestagen Therapy in Hyperplasia and Adenocarcinoma of the Endometrium / T.Fukui et al. / p457~457
  • General Lecture 428.Variation of Cell Kinetics in Endometrial Cancers and Hyperplasias during Progestogen Treatment / A.Yoshizaki et al. / p458~458
  • General Lecture 429.Mitogenic Effect of Progesterone on DMBA-induced Rat Ovarian Cancer--An Experimental Hormone Therapy / N.Kamura et al. / p458~458
  • General Lecture 430.The Cell Kinetics of Endometrial Carcinomas Administered High Dose and Long Term of Sex Steroid Hormones / Y.Matsui et al. / p458~458
  • General Lecture 431.In vitro Hormon Sensitivity Test with Cultured Human Tumor Cell / H.Ohkura et al. / p459~459
  • General Lecture 432.Changes of Estrogen Receptor before and after Chemo-endocrine Therapy for DMBA Induced Rat Mammary Carcinomas / Z.Iwasa et al. / p459~459
  • General Lecture 433.Adjuvant Endocrine Therapy on Breast Cancer with Many Axillary Node Metastases / M.Yoshida et al. / p459~459
  • General Lecture 434.Long-term Follow-up Result of Transsphenoidal Surgical Hypophysectomy for Disseminated Breast Cancer / Y.Higashi et al. / p460~460
  • General Lecture 435.The Usefulness of Ovarian Function Extinguishing Effect in the Postoperative Adjuvant Chemotherapy for Breast Cancer / K.Morimoto et al. / p460~460
  • General Lecture 436.Comparison of Serially Detected Serum PA Values and Clinical Course of Patients with Prostate Cancer Treated with Anti-androgen Therapy : A Study in Americans / M.Kuriyama et al. / p460~460
  • General Lecture 437.Observation of Serum Immunosuppressive Acidic Protein(IAP)Level in Treatment--Process of Head and Neck Cancer Patients / H.Saito et al. / p461~461
  • General Lecture 438.Changes of Serum Concentrations of Immunosuppressive Acidic Protein(IAP)and Glycoproteins, and Skin Tests in Patients with Gastric Cancer before and after Operation / K.Morita et al. / p461~461
  • General Lecture 439.Immunosuppressive Acidic Protein in Patients with Intracranial Tumors / N.Murakami et al. / p461~461
  • General Lecture 440.Measurement of Immunosuppressive Acid Protein(IAP)and Its Clinical Implication / H.Suzuki et al. / p462~462
  • General Lecture 441.IAP and Ferritin in Patients with Urogenital Cancers / Y.Nasu et al. / p462~462
  • General Lecture 442.Acid Soluble Proteins(ASP)in Cancer Patients / M.Tan et al. / p462~462
  • General Lecture 443.Clinical Study on Serum Immunosuppressive Substance(IS)in Lung Cancer Patients / T.Sakai et al. / p463~463
  • General Lecture 444.Evaluation of Serum α₂-globulin Levels in Head and Neck Cancer Patients / M.Miyata et al. / p463~463
  • General Lecture 445.Clinical Investigation of Testicular Tumors for Serum LDH / T.Sugawara et al. / p463~463
  • General Lecture 446.Evaluation of Tumor Marker for Renal Cancer / K.Takahashi et al. / p464~464
  • General Lecture 447.Measurement of Serum Prostatic Acid Phosphatase in Patient with Prostatic Carcinoma--Comparative Study of Radioimmunoassay vs Enzyme Assay / T.Arakawa et al. / p464~464
  • General Lecture 448.Pregnancy Associated α2-Glycoprotein(α2-PAG)in Urogenital Malignancies / T.Misaki et al. / p464~464
  • General Lecture 449.Cellular Retinol-Binding Protein in Human Squamous Cell Carcinomas of the Head and Neck Region / T.Yanagita et al. / p465~465
  • General Lecture 450.A New Simple Enzymatic Assay Method for Urinary Polyamines / T.Yagishita et al. / p465~465
  • General Lecture 451.A Study on Antitumor Effects of Polyamine Biosynthesis Inhibitors for Human Cancer Therapy / R.D.Shrestha et al. / p465~465
  • General Lecture 452.Alteration of Affinity to Lectins of α₁-Antichymotrypsin in the Patients with Malignant Diseases / H.Kidani et al. / p466~466
  • General Lecture 453.Analysis of Elevating Factors in Serum Lipid-bound Sialic Acid(LSA)Level / Y.Uehara et al. / p466~466
  • General Lecture 454.A Role of the Measurement of the Serum Sialic Acid Levels in the Cancer Chemotherapy / I.Nakazawa / p466~466
  • General Lecture 455.Urinary 6-Hydroxymethylpterin Levels in Patients with Solid Tumor / S.Umemoto et al. / p467~467
  • General Lecture 456.Clinical Significance of Urinary 6-hydroxymethylpterin in Cancerous Patients / S.Tsukioka et al. / p467~467
  • General Lecture 457.Diagnostic Value of Urinary Hydroxyproline for Bone Metastasis from Uterine Cervical Cancer / T.Arai et al. / p467~467
  • General Lecture 458.A Study on the Patients(pts)with Carcinoma(ca),Whose Diagnosis of Primary Organ at Operation Were Different from Those at Autopsy--Analysis of Cellular Proteins with 2-dimensional Gel Electrophoresis / S.Sadahiro et al. / p468~468
  • General Lecture 459.Clinical Evaluation of a Thyroxine-Binding Globulin as a Marker of Liver Tumors / S.Terui et al. / p468~468
  • General Lecture 460.Clinical Evaluation of Serum Ferritin-Iron Ratio in Uterine Cervix Cancer with Radiotherapy / S.Nishino et al. / p468~468
  • General Lecture 461.C-terminal Peptide of Type I Procollagen in the Serum as a Tumor Marker of the Schirrhus Gastric Cancer / K.Koda et al. / p469~469
  • General Lecture 462.PNP(Purine Nucleoside Phosphorylase)Activity of Regional Lymphnode Lymphocyte in Patients with Gastric Cancer / T.Kobori et al. / p469~469
  • General Lecture 463.Clinical Significance of the Phosphofructokinase(PFK)-Suppressor in the Sera from the Patients with Gastrointestinal Carcinomas / T.Kitsuta et al. / p469~469
  • General Lecture 464.Thymidine Kinase Isozyme in Colon Cancer / K.Tsukada et al. / p470~470
  • General Lecture 465.Diagnosis of Primary and Secondary Hepatoma with 5'-Nucleotide Phosphodiesterase(5'-NPD)Isozyme Test / H.Ogiwara et al. / p470~470
  • General Lecture 466.The Investigations of the Tongue Cancer Treated by Surgery Alone / W.Ohyama et al. / p470~470
  • General Lecture 467.Post-surgical Course of Hemiglossectomy Cases without Reconstruction / S.Makino et al. / p471~471
  • General Lecture 468.An Evaluation of Neck Dissection in Carcinoma of the Tongue / B.Satake et al. / p471~471
  • General Lecture 469.Partial Pharyngolaryngectomy for Pyriform Sinus Cancer / S.Takemiya et al. / p471~471
  • General Lecture 470.The Ligation of the Carotid Artery in Head and Neck Cancer / T.Yabe et al. / p472~472
  • General Lecture 471.Closure of Head and Neck Defects with Free Forearm Flap / T.Takato et al. / p472~472
  • General Lecture 472.Reconstruction of Cervical Esophagus and Oral Cavity by Microsurgical Transfer of Small Intestine / T.Harashina et al. / p472~472
  • General Lecture 473.Resection of Thyroid Carcinoma Invading the Trachea / T.Ishihara et al. / p473~473
  • General Lecture 474.A Clinicopathological Study of Recurrent Pattern of Primary Liver Cell Carcinoma(PLC) / T.Kusano et al. / p473~473
  • General Lecture 475.Diagnosis and Treatment of Cholangiocarcinoma / H.Yamase et al. / p473~473
  • General Lecture 476.Hepatocellular Carcinoma Recurring after Hepatic Resection / S.Imaoka et al. / p474~474
  • General Lecture 477.Diagnosis and Operation for Locally Recurrent Rectal Cancer / H.Takagi et al. / p474~474
  • General Lecture 478.A Newly-developed Pancreaticoduodenectomy / H.Katoh et al. / p474~474
  • General Lecture 479.Right Hemicolectomy, Approach from Root of Mesenterium / M.Furusawa et al. / p475~475
  • General Lecture 480.Significance of Hepatic and Pulmonary Resection for Metastasis from Colorectal Cancer / T.Ikeda et al. / p475~475
  • General Lecture 481.Surgical Management of Pelvic Tumors / S.Osaka et al. / p475~475
  • General Lecture 482.Massive Segmental Bone Grafting after Wide en bloc Resection of Malignant Bone Tumors / S.Masuda et al. / p476~476
  • General Lecture 483.Clinicopathological Study of 197 Cases of Early Gastric Cancer / H.Hirakawa et al. / p476~476
  • General Lecture 484.Recurrence after Radical Surgery for Gastric Carcinoma--Eight Cases Who Died Eight or More Years after Surgery / T.Ichikawa et al. / p476~476
  • General Lecture 485.End Results of Geriatric Patients with Gastric Cancer / E.Yamane et al. / p477~477
  • General Lecture 486.Gastric Cancers of Young Adults Aged 34 or Below / H.Furukawa et al. / p477~477
  • General Lecture 487.Cases of Long Term Survivors in Advanced Gastric Cancer, Borrmann 4 Type / K.Hayakawa et al. / p477~477
  • General Lecture 488.Progress of Linitis Platica Type of Gastric Carcinoma and Operative Results--Analysis by Preoperative Roentgenography / H.Nomura et al. / p478~478
  • General Lecture 489.A Study on the Relationship between the Prognosis and Clinicopathologic Findings and Treatments of Stage IV Gastric Cancer / T.Nakamura et al. / p478~478
  • General Lecture 490.Randomized Study on the Long-term Adjuvant Chemotherapy with Futraful and Mitomycin C for Gastric Cancer
  • Second Study(A Third Report) / T.Muto et al. / p478~478
  • General Lecture 491.Randomized Clinical Trial of Adjuvant Chemotherapy with CPA Curatively Resected Patients with Stomach Cancer / H.Nakazato et al. / p479~479
  • General Lecture 492.A Sequential Chemotherapy Using Mitomycin C and Tegafur in the Treatment of Gastric Cancer after Gastrectomy I.Patient Characteristics and Safety of Regimens / K.Koizumi et al. / p479~479
  • General Lecture 493.Intraperitoneal Administration of Anticancer Drug for Gastric Cancer with Serosal Invasion(First Report) / Y.Ohmori et al. / p479~479
  • General Lecture 494.Data-base Evaluation of Non-randomized Adjuvant Chemotherapy for Gastric Cancer / T.Nakajima et al. / p480~480
  • General Lecture 495.Evaluation of Postoperative Adjuvant Chemotherapy for Gastric Cancer Based on the Relative Hazard Rate / M.Kikuchi et al. / p480~480
  • General Lecture 496.Not Received / /
  • General Lecture 497.Practice of UFTM Chemotherapy for Borrmann Type 4 Gastric Cancer / H.Iwase et al. / p480~480
  • General Lecture 498.Chemotherapy Effect of UFT Enhanced by MMC against Far Advanced Gastric Cancer / S.Yoshida et al. / p481~481
  • General Lecture 499.Study on the MFVC-OK Therapy against Inoperable Gastric Cancer, Especially with Poorly Type(6th Report) / Y.Sakata et al. / p481~481
  • General Lecture 500.AMUFT(Doxorubicin, Mitomycin C, and UFT)Regimen for Advanced Gastric Cancer / M.Murakami et al. / p481~481
  • General Lecture 501.The Study of the Prolongation of Survival Period by Cancer Chemotherapy on Gastric Carcinoma in the Terminal Stage / Y.Inoue et al. / p482~482
  • General Lecture 502.A Combination Chemotherapy with ACNU or Adriamycin and 5-FU for End Stage Gastric Cancer / Y.Rai et al. / p482~482
  • General Lecture 503.Combination Immuno-Chemotherapy of Inoperable Gastric Cancer with ACNU, 5-fluorouracil and OK432(II) / M.Fujii et al. / p482~482
  • General Lecture 504.Combined Modality Therapy of Metastatic Hepatic Disease / S.Kitagawa et al. / p483~483
  • General Lecture 505.Postoperative Chemotherapy for the Pancreas Carcinoma / H.Oohigashi et al. / p483~483
  • General Lecture 506.Clinical Studies on the Administration of Neocarzinostatin (NCS) for Advanced and Recurrent Carcinoma of the Pancreas / Y.Kunii et al. / p483~483
  • General Lecture 507.MFP Therapy for Peritonitis Carcinomatosa / T.Nakagawa et al. / p484~484
  • General Lecture 508.Prophylactic Intravesical Instillation Therapy with Adriamycin(ADM)and Mitomycin C(MMC)in Patients with Superficial Bladder Cancer / Y.Ozaki et al. / p484~484
  • General Lecture 509.Early Prophylactic, Low Dose and Continuous Intravesical Irrigation Therapy after TUR in Superficial Bladder Tumors / T.Uchida et al. / p484~484
  • General Lecture 510.Development and Clinical Application of ACF Regimen / T.Kobayashi et al. / p485~485
  • General Lecture 511.Postoperative Prognosis of 163 Lung Cancer Patients with Clinical Stage I Disease / S.Fukai et al. / p485~485
  • General Lecture 512.Lung Cancer in Young Persons / H.Ayabe et al. / p485~485
  • General Lecture 513.Results of Absolute Non-curative Resection for Colorectal Carcinoma / T.Sekine et al. / p486~486
  • General Lecture 514.Prognosis of Resected Sigmoid Colon Cancer Related to Clinico-pathological Findings and Operative Procedures / A.Ouchi et al. / p486~486
  • General Lecture 515.Cases of Malignant Tumors of the Biliary Tract / T.Tamio et al. / p486~486
  • General Lecture 516.Late Effects of Anticancer Treatment on Long Term Survivors with Pediatric Malignancies / S.Shimizu et al. / p487~487
  • General Lecture 517.Malignant Lymphoma in Childhood
  • From the Surgical Point of View / K.Shibata et al. / p487~487
  • General Lecture 518.Cell Kinetics of Metastatic C 1300 Murine Neuroblastoma Cell after Cyclophosphamide Administration / H.Sakatoku et al. / p487~487
  • General Lecture 519.Experimental and Clinical Studies on Adjuvant Therapy for Advanced Neuroblastoma / E.Arima et al. / p488~488
  • General Lecture 520.Results of Multidisciplinary Treatment for Maxillary Antrum Cancer / T.Teshima et al. / p488~488
  • General Lecture 521.Patterns of Relapse and Prognostic Factors of Squamous Cell Carcinoma of the Maxillary Sinus / M.Kondo et al. / p488~488
  • General Lecture 522.The Therapy for Recurrent and Metastatic Cases of Head and Neck Cancer / T.Honda et al. / p489~489
  • General Lecture 523.Some Considerations in the Progress of Laryngeal Carcinoma--Relationship of Duration of Hoarseness and Tumor Growth / S.Matsuura et al. / p489~489
  • General Lecture 524.Treatment of Anaplastic Carcinoma of the Thyroid Gland / M.Izukura et al. / p489~489
  • General Lecture 525.Factors Affecting the Prognosis of Papillary Carcinoma of the Thyroid / M.Hodo et al. / p490~490
  • General Lecture 526.Patterns of Relapse of Non-Hodgkin Lymphoma of the Waldeyer's Ring / M.Kondo et al. / p490~490
  • General Lecture 527.Mode of Recurrence and Prognosis on Non-Hodgkin's Lymphoma of Waldeyer's Ring / T.Takenaka et al. / p490~490
  • General Lecture 528.Survival and Factors Related to the Survival of Recurrent Breast Cancer Patients--A Study with Quantification Theory / Y.Murayama et al. / p491~491
  • General Lecture 529.Studies on Breast Cancer with Redness and/or Edema of the Skin / M.Nagino et al. / p491~491
  • General Lecture 530.Influence of Pre-operative Biopsy of the Breast Carcinoma on Its Survival Rate / A.Fujiwara et al. / p491~491
  • General Lecture 531.Studies of Recurrent Stage I (TNM) Breast Cancer / H.Yamashita et al. / p492~492
  • General Lecture 532.Effect of Adjuvant Chemotherapy in Cases of Breast Cancer without Nodal Involvement / S.Miura et al. / p492~492
  • General Lecture 533.Breast Cancer with Pleuritis Carcinomatosa / T.Ito et al. / p492~492
  • General Lecture 534.Effect of a Possible Target-oriented Anticancer Agent(KM2210,Estradiol-Chlorambu-cil)on Recurrent or Far Advanced Breast Cancer / Z.Yamazaki et al. / p493~493
  • General Lecture 535.Response of Recurrent and Metastatic Breast Cancer to Peplomycin / M.Numata et al. / p493~493
  • General Lecture 536.Anti-tumor Effect of Peplomycin on Breast Cancer / Y.Hata et al. / p493~493
  • General Lecture 537.Clinical Evaluation of Adriamycin for Advanced and Recurrent Breast Cancer (No.3) -A Joint Study by 26 Institutes on the CAF and CMcF Regimens / K.Kubo et al. / p494~494
  • General Lecture 538.Hormone-chemotherapy of Pulmonary Metastasis of Breast Cancer with Cyclophospha-mide,Adriamycin,Prednisolone and Tamoxifen(CAPT) / Y.Nakamura et al. / p494~494
  • General Lecture 539.Chemo-endocrine Therapy with Tamoxifen,Tegafur and Low-dose Adriamycin for Treatment of Breast Cancer / T.Wada et al. / p494~494
  • General Lecture 540.Prospective Randomized Trial of Chemo-endocrine Therapy for Advanced Breast Cancer / H.Tashiro et al. / p495~495
  • General Lecture 541.Basic Study on Chemo-endocrine Therapy for Breast Cancer / T.Ikeda et al. / p495~495
  • General Lecture 542.Bronchofiberscopic Findings of Intrathoracic Involvement of Malignant Lymphoma / K.Tsunematsu et al. / p495~495
  • General Lecture 543.Combination Therapy of Vinca Alkaloids and Nicardipine in Patients with Non-Hodgkin's Lymphoma Who Became Resistant to Various Chemotherapeutic Agents and Relapsed / T.Honda et al. / p496~496
  • General Lecture 544.Combination Chemotherapy for Non-Hodgkin's Lymphoma Except for Large Cell Type with Adriamycin,Vincristine,Ifosfamide and Prednisolone(AVIP) / H.Ueoka et al. / p496~496
  • General Lecture 545.Combined Chemotherapy for Undifferentiated Small Cell Carcinoma of the Esophagus / K.Taniguchi et al. / p496~496
  • General Lecture 546.Treatment of Inoperative Esophageal Cancer by Oral Administration of Oil Bleomycin / J.Tamura et al. / p497~497
  • General Lecture 547.Nebulization Chemotherapy in Treatment of Tracheal and Bronchial Carcinomas / T.Tatsumura et al. / p497~497
  • General Lecture 548.Evaluation of Therapeutic Effect of MTX with Leucovorin Rescue for Gestational Trophoblastic Disease / H.Uchino et al. / p497~497
  • General Lecture 549.High Dose MTX/CF Rescue Therapy in Patients with Hemopoietic Neoplasmas & Solid Tumors / Y.Kobayashi et al. / p498~498
  • General Lecture 550.Phase I-II Study of 7-N-(p-hydroxyphenyl)-mitomycin C / S.Meguro et al. / p498~498
  • General Lecture 551.Phase II Study of KW-2083 in Patients with Lung Cancer and Metastatic Pulmonary Tumor / T.Shinkai et al. / p498~498
  • General Lecture 552.Clinical Studies on NK-171 for Advanced and Recurrent Cancer Patients / K.Yoshinaka et al. / p499~499
  • General Lecture 553.VP-16 in Small Cell Carcinoma of the Lung / Y.Kurita et al. / p499~499
  • General Lecture 554.Trials of VP-16 Containing Combination Chemotherapy for Advanced Lymphomas Refractory to Combination Chemotherapy / A.Oyama et al. / p499~499
  • General Lecture 555.Clinical Appearance of Testis Tumors with Positive Human Chorionic Gonadotropin / T.Kawai et al. / p500~500
  • General Lecture 556.Indication and Treatment Result of Testicular Tumors / M.Maruoka et al. / p500~500
  • General Lecture 557.Results of Treatment for Pure Seminoma of the Testis / S.Komatsubara et al. / p500~500
  • General Lecture 558.Results of Treatment for Non-seminomatous Tumor of Testis / S.Komatsubara et al. / p501~501
  • General Lecture 559.Clinical Observation of Prostatic Cancer / H.Morita et al. / p501~501
  • General Lecture 560.Factors Affecting Prognosis of Stage D Prostatic Cancer after Endocrine Therapy / T.Masukagami et al. / p501~501
  • General Lecture 561.Clinical Investigation of Testicular Tumor / A.Furuhata et al. / p502~502
  • General Lecture 562.A Case of Successful Treatment of Advanced Seminoma / K.Hakamata et al. / p502~502
  • General Lecture 563.Prognosis of Germ Cell Tumor of the Testis / T.Miyauchi et al. / p502~502
  • General Lecture 564.Chemotherapy for Patients with Refractory,Advanced Testicular Tumor / K.Nakamura et al. / p503~503
  • General Lecture 565.VM-26 Salvage Therapy for Refractory Testicular Cancers / H.Oda et al. / p503~503
  • General Lecture 566.Management of Patients with Stage I Ovarian Cancer / H.Nishimura et al. / p503~503
  • General Lecture 567.Management of Stage I Ovarian Cancer / S.Isonishi et al. / p504~504
  • General Lecture 568.Clinical and Pathological Analysis on Malignant Ovarian Tumor--Second Look Operation / T.Matsukuma et al. / p504~504
  • General Lecture 569.Some Considerations Regarding to Maintain Reproducibility in Patients with Malignant Ovarian Tumors / T.Miyazaki et al. / p504~504
  • General Lecture 570.T Lymphocytes Subsets of Patients with Cancer in the Head and Neck / T.Furusaka et al. / p505~505
  • General Lecture 571.PHA Lymphocyte Stimulation Test(2nd Report) / K.Ietomi et al. / p505~505
  • General Lecture 572.The Effect of Histamine on Blastoid Transformation of Human Lymphocytes / T.Motoki et al. / p505~505
  • General Lecture 573.Enhancement of in vitro Lymphocyte Proliferative Response by Vitamin B Compound / T.Toge et al. / p506~506
  • General Lecture 574.Evaluation of Fluorescence Polarization of Human Lymphocytes (SCM test)in the Diagnosis of Gynecologic Cancer / T.Tenzaki et al. / p506~506
  • General Lecture 575.Study of Indomethacin Sensitive Suppressor Cells against Gastric and Colon Cancer Peripheral Lymphocyte Tumor Extract Reactions / H.Nakanishi et al. / p506~506
  • General Lecture 576.Analysis of T-cell Subset Changes in Patients with Malignant Brain Tumors from the Viewpoint of Monoclonal Antibody / S.Yoshida et al. / p507~507
  • General Lecture 577.Natural Killer Activity of Regional Lymph Node Cells from Cancer Patient with Gastric Cancer / F.Koba et al. / p507~507
  • General Lecture 578.Natural Killer Cell Activity in Patients with Malignant Lymphoma / M.Nishikori et al. / p507~507
  • General Lecture 579.Depression of the Generation of Cell-Mediated Cytotoxicity after Surgery in Cancer Patients / S.Miyazaki et al. / p508~508
  • General Lecture 580.Activation of Suppressor Macrophage by Serum or Immunosuppressive Substance(ISS)of Patient with Gastric and Colon Cancer / K.Ohnishi et al. / p508~508
  • General Lecture 581.ADCC Activity on Patients with Cancer and Influence by Its Treatment / T.Takahashi et al. / p508~508
  • General Lecture 582.Evaluation of Immunological Parameters of Gastric Carcinoma / S.Kanabe et al. / p509~509
  • General Lecture 583.Follow up Studies of NK Activity and Other Immuno Parameters Patients with Digestive Tract Cancer / T.Beika et al. / p509~509
  • General Lecture 584.Estimating Prognosis of the Patients with Advanced Cervical Cancer from Tumor Marker and Immunological Parameter / Y.Matsuura et al. / p509~509
  • General Lecture 585.Studies on the Tumor-host Relationship in Oral Cancer 2.Regional Lymph Node Metastasis / S.Miyauchi et al / p510~510
  • General Lecture 586.Cellular Immunological Variation Due to the Treatment of Esophageal Carcinoma:Influence of Pre-Operative Irradiation and Operative Stress / Y.Nakata et al. / p510~510
  • General Lecture 587.Tumor Immunity in Thyroid Carcinoma:Possibility of Induction of Host's Anti-Tumor Immunological Responses by ¹³¹ I Therapy / A Sugenoya et al. / p510~510
  • General Lecture 588.Inactivation of Immunosuppressive Factor in Ascitic Fluid of Patient with Gastro-intestinal Cancer / K.Amemiya et al. / p511~511
  • General Lecture 589.Studies of Blood Group Isoantigen Specificity:Carcinoma in situ and Non-Malignant Bladder Lesions / H.Takigawa et al. / p511~511
  • General Lecture 590.Not Received / /
  • General Lecture 591.Enhancing Effect of Mitomycin C on Hematogeneous Metastases of Ascites Hepatoma in Rat / K.Murasawa / p511~511
  • General Lecture 592.The Significance of Administration of Anabolic Steroid on Post-Operative Condition of the Cancer Patients / Y.Ooshika et al. / p512~512
  • General Lecture 593.Radiation Treatment of Cancer of the Esophagus / M.Hareyama et al. / p512~512
  • General Lecture 594.Combined Therapy of Esophageal Carcinoma / G.Shirozu et al. / p512~512
  • General Lecture 595.Radiation Treatment of Esophageal Carcinoma Using High Dose Rate Remote Afterloader / Y.Hishikawa et al. / p513~513
  • General Lecture 596.Radiotherapy for Esophageal Carcinomas with Bronchoesophageal Fistula / S.Yamada et al. / p513~513
  • General Lecture 597.Histopathologic Effect of Irradiation on Esophageal Cancer / K Nishikawa et al. / p513~513
  • General Lecture 598.The Infiltration and Deterrence in the Esophageal Wall of the Upper Gastric Cancer, and the Determination of the Resectional Line for Progressive Upper Gastric Cancer / H.Joko et al. / p514~514
  • General Lecture 599.Intraoperative Radiotherapy in Treatment for Gastric Cancer / K.Miwa et al. / p514~514
  • General Lecture 600.Preoperative Combined Therapy with Irradiation and Chemotherapy on the Advanced Gastric Cancer in Cardio-esophageal Region / I.Takagi et al. / p514~514
  • General Lecture 601.Studies on Resected Gastric Carcinomas Treated with Intra-abdominal Administration of ¹⁹⁸Au Colloid / T.Saito et al. / p515~515
  • General Lecture 602.The Role of Irradiation in Multi-disciplinary Treatments of Primary Hepatoma / M.Ryu et al. / p515~515
  • General Lecture 603.Significance of Intraluminal Irradiation as a Surgical Adjuvant Therapy for Carcinoma of the Proximal Bile Duct / Y.Abe et al. / p515~515
  • General Lecture 604.Experiences of Fast Neutron Irradiation Therapy in Liver and Biliary Tract Cancers / T.Nagashima et al. / p516~516
  • General Lecture 605.Survey of X-ray Sensitivity of Human Lung Carcinoma in vitro / S.Okada et al. / p516~516
  • General Lecture 606.Multidisciplinary Treatment against Small Cell Lung Cancer / N.Saijo et al. / p516~516
  • General Lecture 607.Small-Cell Carcinoma of the Lung:Combined Chemotherapy and Radiation / Y.Takahashi et al. / p517~517
  • General Lecture 608.Radiotherapy of Primary Lung Cancer / H.Shirato et al. / p517~517
  • General Lecture 609.Radiotherapy for Lung Cancer / T.Sugimoto et al. / p517~517
  • General Lecture 610.Evaluation of Once-a-week Single High Dose Irradiation for Lung Cancer / A.Mikami et al. / p518~518
  • General Lecture 611.Experimental Radiotherapy of Human Urogenital Malignant Neoplasms Transplantable to Nude Mice / J.Hasegawa et al. / p518~518
  • General Lecture 612.Preoperative Irradiation and Radical Cystectomy for Bladder Cancer / M.Miyakawa et al. / p518~518
  • General Lecture 613.Role of Preoperative Irradiation of Bladder Carcinoma / T.Kamada et al. / p519~519
  • General Lecture 614.Evaluation of Post-operative Irradiation in Breast Cancer / J.Ito et al. / p519~519
  • General Lecture 615.Evaluation of Postoperative Radiotherapy by the Moving Strip Technique for Primary Ovarian Cancer / Y.Katsube et al. / p519~519
  • General Lecture 616.Ir-192 Remoto Afterloading System for High Dose-rate Intracavitary Irradiation / G.Uchiyama et al. / p520~520
  • General Lecture 617.Augmentation of CT-number Enhanced by Angiographin in Tumors Administered Fibrinolytic Agents (UK and LMWD) / T.Ogino et al. / p520~520
  • General Lecture 618.Studies on Serum and Lymphocytes Levels of Superoxide Dismutase (SOD) in Human Carcinomas / J.Sato et al. / p520~520
  • General Lecture 619.Clinical Radio Protective Anti-inflammatory Effects by Super Oxide Dismutase (Orgo-tein) / T.Kaneda et al. / p521~521
  • General Lecture 620.Study on the Radioprotective Effect of Amifostine(YM-08310)with the Double Blind Method / H.Niibe et al. / p521~521
  • General Lecture 621.Tumour Kinetics and the Timing of the Second Dose to Obtain a Better Radiocurability of the Tumour / Y.Takaki / p521~521
  • General Lecture 622.Comparison of the Effect between an Active Specific Immunotherapy Using the Immune Reaction of a Low-dose Irradiated Tumor Tissue and That Using Irradiated Tumor Cells / Y.Ogawa et al. / p522~522
  • General Lecture 623.The Radioprotective Effect of WR-2721 in Head and Neck Tumors / H.Tsujii et al. / p522~522
  • General Lecture 624.Plasma Prolactin Levels in Patients with Postoperative Breast Cancer--Effects of Nauzelin on Plasma Prolactin Levels / M.Endow et al. / p522~522
  • General Lecture 625.Clinical Evaluation of Nauzelin as an Antiemetic in Patients Receiving Chemotherapy and/or Radiotherapy / K.Sekiguchi et al. / p523~523
  • General Lecture 626.Efficacy of Bioclean Room for the Protection from Infection in Treatment of Carcinoma of the Lung / N.Sawamura et al. / p523~523
  • General Lecture 627.Tumor Inhibition Effect of Ultrasound--Experimental Study / R.Akimoto et al. / p523~523
  • General Lecture 628.Not Received / /
  • General Lecture 629.Anti-tumor Effect Induced by Microwave Coagulation for Tumor / H.Noguchi et al. / p524~524
  • General Lecture 630.Effect of Coagulation Therapy on Microwave Tissue Coagulator for Malignant Tumor Regarding the Incidence of Metastasis / H.Yamaue et al. / p524~524
  • General Lecture 631.Molding Chemoembolization by Fibrin Clot Containing Anticancer Drug / J.Itoh et al. / p524~524
  • General Lecture 632.Not Received / /
  • General Lecture 633.A Clinical and Experimental Study of the Intermittent Hepatic Artery Occlusion(IHAO)with Infusion Chemotherapy for the Unresectable Hepatocellular Carcinoma(HCC) / A.Naitoh et al. / p525~525
  • General Lecture 634.Hepatic Artery Embolization for Metastatic Liver Tumor / K.Ogawa et al. / p525~525
  • General Lecture 635.Not Received / /
  • General Lecture 636.Ferromagnetic Microembolization in the Treatment of Hepatomas:The Therapeutic Effect on the Daughter Nodules / H.Yuri et al. / p525~525
  • General Lecture 637.Transarterial Embolization during the Operation for Hepatoma / K.Hori et al. / p526~526
  • General Lecture 638.Effect of Pre-operative TAE on Liver Regeneration in the Rats / O.Takahashi et al. / p526~526
  • General Lecture 639.Pathohistological Study Concerning the Resected Hepatocellular Carcinoma Treated with Preoperative Transcatheter Arterial Embolization / T.Sonoyama et al. / p526~526
  • General Lecture 640.Studies on Embolotherapy of Lung Cancer / M.Morita et al. / p527~527
  • General Lecture 641.Clinical Studies on Transcatheter Embolization of Renal Artery for Renal Cell Carcinoma / K.Yoneda et al. / p527~527
  • General Lecture 642.Experience in the Treatment of Renal Carcinoma through Usage of Balloon Catheter / I.Murahashi et al. / p527~527
  • General Lecture 643.Balloon-assisted Renal Embolization with Absolute Ethanol / H.Kobayashi et al. / p528~528
  • General Lecture 644.Arterial Embolization:Effectiveness and Limitation to the Cancer / Y.Watanabe et al. / p528~528
  • General Lecture 645.Side Effect of Hepatic Artery Embolization--Compatible Ivalon and Gelatine Sponge / K.Ido et al. / p528~528
  • General Lecture 646.Computed Tomography of the Nasopharyngeal Carcinoma / S.Yamashita et al. / p529~529
  • General Lecture 647.Clinical Diagnosis Significance of Computed Tomography in Laryngeal Carcinoma / S.Takeoda et al. / p529~529
  • General Lecture 648.Computed Tomography in Carcinoma of Esophagus / T.Fukuda et al. / p529~529
  • General Lecture 649.The Use of Computed Tomography(CT)to Evaluate Anterior Mediastinal Tumors / T.Suito et al. / p530~530
  • General Lecture 650.The Analysis of the CT Scans of Ovarian Tumors / R.Akiba et al. / p530~530
  • General Lecture 651.The Usefullness of Computerized Tomography in Ovarian Cancer Treatment / M.Murae et al. / p530~530
  • General Lecture 652.CT Staging of Urinary Bladder Carcinoma / H.Kiyohara et al. / p531~531
  • General Lecture 653.The Value of CT Scan in Pelvic Exenteration / T.Hayashi et al. / p531~531
  • General Lecture 654.Clinical Application of Nuclear Magnetic Resonance Computed Tomography(NMR-CT)in Prostatic Lesions / T.Hara et al. / p531~531
  • General Lecture 655.In vivo NMR Studies on Tumors / S.Naruse et al. / p532~532
  • General Lecture 656.Image Diagnosis in the Staging of Urinary Bladder Cancer / A.Iwai et al. / p532~532
  • General Lecture 657.Study of Liver Ultrasonography by Selective Arterial Injection of Fat Emulsion / H.Mizutani et al. / p532~532
  • General Lecture 658.The Use of Sonolaproscope in Diagnosis of Hepatocellular Carcinoma / K.Hirata et al. / p533~533
  • General Lecture 659.Differential Diagnosis of Ovarian Tumors Images and Biochemical Parameters / S.Katashima et al. / p533~533
  • General Lecture 660.Diagnostic Study on Malignant Ovarian Tumors by Ultrasonography / M.Akamine et al. / p533~533
  • General Lecture 661.Applicability of Transurethral Intravesical Radial Scan Ultrasonography(RSUSG)for Estimating the Urinary Bladder Invasion of Cervical Cancer / M.Nishi et al. / p534~534
  • General Lecture 662.Significance of 67Ga and 201T1 Scintigraphy in Thyroid Cancer of Advanced, Recurrent,and Metastatic Cases / N.Kasai et al. / p534~534
  • General Lecture 663.Lymphography(LG)and Lymphoscintigraphy(LS)in Urogenital Malignancies(Second Report) / Y.Furukawa et al. / p534~534
  • General Lecture 664.Estimation of Growth Pattern of Endometrial Carcinoma by Selective Hysterography / S.Inui et al. / p535~535
  • General Lecture 665.Endoscopic Local Injection of Adriamycin(ADR)into Canine Gastric Cancer Induced by N-ethy-N'-nitro-N-nitrosoguanidine(ENNG) / T.Ogawa et al. / p535~535
  • General Lecture 666.Preoperatively Endoscopic Injection of the MMC-adsorbed Activated Carbon for the Gastric Cancer / T.Ueda et al. / p535~535
  • General Lecture 667.A Study on Endoscopic Local Injection (ELI) of Anticancer Agents for Gastric Carcinoma / A.Nashimoto et al. / p536~536
  • General Lecture 668.Endoscopic Cryosurgery on Advanced Cancer of Gastro-intestinal Tract / Y.Tsujimoto et al. / p536~536
  • General Lecture 669.Slow-releasing Polymer Antitumor Capsule for Treatment of Urological Malignancies / J.Sakatoku et al. / p536~536
  • General Lecture 670.Clinical Application of Encapsulated Anti-cancer Drug X. Effect on Renal Cancer as a Preoperative Adjuvant / R.Abe et al. / p537~537
  • General Lecture 671.Clinical Application of Microencapsulated Anticancer Drug Ⅺ. Effects on Organ Preserving Operation for Invasive Bladder Carcinoma / K.Sato et al. / p537~537
  • General Lecture 672.Intra-arterial Infusion of Micro-encapsulated Mitomycin C in the Treatment of Unresectable Hepatoma(3rd Report) / Y.Tsuji et al. / p537~537
  • General Lecture 673.Clinical Studies of Cancer Chemotherapy Combined with Angiotensin-II / N.Takahashi et al. / p538~538
  • General Lecture 674.Randomized Controlled Study on Induced Hypertension Chemotherapy / H.Sato et al. / p538~538
  • Scientific Exhibition 1.Two Cases of Prolonged Survivor with Multiple Pulmonary Metastases / M.Yamauchi et al. / p539~539
  • Scientific Exhibition 2.A Case of Chemotherapeutically Controlled Post-operative Lung Metastasis of Cervical Cancer / T.Kasamatsu et al. / p539~539
  • Scientific Exhibition 3.A Case of Metastatic Carcinoma of the Liver with a Primary Lesion in the Colon, Surviving for Three Years and Eight Months after Hepatic Resection (Right Lobe) Done Twice / T.Ohgane et al. / p539~539
  • Scientific Exhibition 4.A Five-year Follow-up of the Treatment of Advanced Gastric Carcinoma Associated with Portal Vein Tumor Embolism by the Appleby Operation / H.Koizumi et al. / p540~540
  • Scientific Exhibition 5.A Long Survival Case of Esophageal Carcinoma with Repeated Recurrence after Total Esophagectomy / K.Kobayashi et al. / p540~540
  • Scientific Exhibition 6.Not Received / /
  • Scientific Exhibition 7.Primary Osteogenic of the Skull, Case Report / S.Ito et al. / p540~540
  • Scientific Exhibition 8.Clinical Evaluation of Computer Controlled Conformation Radiotherapy / T.Matsuda et al. / p541~541
  • Scientific Exhibition 9.Not Received / /

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology

Nihon gan chiryo gakkaishi
巻冊次 19(2)
出版元 日本癌治療学会
刊行年月 1984-03
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想